<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US6277609B1 - Method to produce biotin 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US6277609B1/en">
    <meta name="description" content="
     The pesent invention is directed to biotin-producing recombinant cells transformed with an  Escherichia coli  bioE gene or a functional equivalent thereof, either alone or in combination with at least one additional nucleic acid sequence selected from  Bacillus sphaericus  bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or a functional equivalent of any of these genes. Preferred recombinant cells are capable of converting essentially all biotin vitamers to true biotin. The present invention also provides a method to produce biotin by culturing such recombinant cells under appropriate conditions in an effective medium, which preferably includes biotin precursor supplements. The present invention is also directed to recombinant cells transformed with an  Escherichia coli  bioH gene, or functional equivalent thereof, either alone or with at least one nucleic acid selected from the group consisting of  Escherichia coli  bioA, bioB, bioC, bioD, bioE, and bioF genes, and functional equivalents thereof, said recombinant cells being capable of producing more biotin than a cell not transformed with an  Escherichia coli  bioH gene, or functional equivalent thereof; and use of such cells to produce biotin. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Method to produce biotin 
       ">
    <meta name="DC.date" content="1993-01-06" scheme="dateSubmitted">
    <meta name="DC.description" content="
     The pesent invention is directed to biotin-producing recombinant cells transformed with an  Escherichia coli  bioE gene or a functional equivalent thereof, either alone or in combination with at least one additional nucleic acid sequence selected from  Bacillus sphaericus  bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or a functional equivalent of any of these genes. Preferred recombinant cells are capable of converting essentially all biotin vitamers to true biotin. The present invention also provides a method to produce biotin by culturing such recombinant cells under appropriate conditions in an effective medium, which preferably includes biotin precursor supplements. The present invention is also directed to recombinant cells transformed with an  Escherichia coli  bioH gene, or functional equivalent thereof, either alone or with at least one nucleic acid selected from the group consisting of  Escherichia coli  bioA, bioB, bioC, bioD, bioE, and bioF genes, and functional equivalents thereof, said recombinant cells being capable of producing more biotin than a cell not transformed with an  Escherichia coli  bioH gene, or functional equivalent thereof; and use of such cells to produce biotin. 
   
   ">
    <meta name="citation_patent_application_number" content="US:08/001,063">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/c7/a7/61/87a62099ea33ae/US6277609.pdf">
    <meta name="citation_patent_number" content="US:6277609">
    <meta name="DC.date" content="2001-08-21" scheme="issue">
    <meta name="DC.contributor" content="Christina K. Eddy" scheme="inventor">
    <meta name="DC.contributor" content="BASF SE" scheme="assignee">
    <meta name="DC.relation" content="US:3393129" scheme="references">
    <meta name="DC.relation" content="US:4563426" scheme="references">
    <meta name="DC.relation" content="JP:S61149091:A" scheme="references">
    <meta name="DC.relation" content="JP:S61202686:A" scheme="references">
    <meta name="DC.relation" content="US:5110731" scheme="references">
    <meta name="DC.relation" content="JP:S62155081:A" scheme="references">
    <meta name="DC.relation" content="EP:0240105:A1" scheme="references">
    <meta name="DC.relation" content="EP:0266240:A1" scheme="references">
    <meta name="DC.relation" content="US:5096823" scheme="references">
    <meta name="DC.relation" content="EP:0316229:A1" scheme="references">
    <meta name="DC.relation" content="GB:2216530:A" scheme="references">
    <meta name="DC.relation" content="EP:0375525:A1" scheme="references">
    <meta name="DC.relation" content="EP:0379428:A1" scheme="references">
    <meta name="DC.relation" content="US:5212058" scheme="references">
    <meta name="citation_reference" content="Brown et al., &quot;The Production of Biotin by Genetically Modified Micro-organisms&quot;, pp. 295-326, 1991 Biotechnology and Genetic Engineering Reviews, vol. 9, Dec." scheme="references">
    <meta name="citation_reference" content="Cleary et al., &quot;Location of Promoter and Operator Sites in the Biotin Gene Cluster of Escherichia coli&quot;, pp. 2219-2223, 1972, Proc. Natl. Acad. Sci., vol. 69." scheme="references">
    <meta name="citation_reference" content="Eisenberg, &quot;Biosynthesis of Biotin and Lipoic Acid&quot;, pp. 544-550, 1987, in Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology, Neidhardt, F.C. et al., eds., American Society of Biology, Washington, D.C." scheme="references">
    <meta name="citation_reference" content="Gloeckler et al., &quot;Cloning and Characterization of the Bacillus sphaericus Genes Controlling the Bioconversion of Pimelate into Dethiobiotin&quot;, pp. 63-70, 1990, Gene, vol. 87." scheme="references">
    <meta name="citation_reference" content="Guha et al., &quot;Divergent Orientation of Transcription from the Biotin Locus of Escherichia coli&quot;, pp. 53-62, 1971, J. Mol. Biol., vol. 56." scheme="references">
    <meta name="citation_reference" content="Izumi et al., from &quot;Microbial Production of Biotin&quot;, pp. 242-243, 1989, in Biotechnology of Vitamins, Pigments, and Growth Factors, Elsevier Applied Science (E.J. Vandamme, ed.)." scheme="references">
    <meta name="citation_reference" content="Magnuson et al., &quot;Cloning and Nucleotide Sequence of the fabD Gene Encoding Malonyl Coenzyme A-acyl Carrier Protein Transacylase of Escherichia coli&quot;, pp. 262-266, 1992, FEBS Letters, vol. 229." scheme="references">
    <meta name="citation_reference" content="Ogata et al., &quot;Studies on Biosynthesis on Biotin by Microorganisms. Part I. Accumulation of Biotin-Vitamers by Various Microorganisms&quot;, pp. 889-894, 1965, Agr. Biol. Chem., vol. 29." scheme="references">
    <meta name="citation_reference" content="Ogata et al., &quot;Studies on Biosynthesis on Biotin by Microorganisms. Part II. Identification of Biotin-Vitamers Accumulated by Various Microorganisms&quot;, pp. 895-901, 1965, Agr. Biol. Chem., vol. 29." scheme="references">
    <meta name="citation_reference" content="Ogata, &quot;Microbial Synthesis of Dethiobiotin and Biotin&quot;, pp. 390-395, 1970, Methods in Enzymology, vol. 17a." scheme="references">
    <meta name="citation_reference" content="Ohsawa et al., &quot;Bioconversion of Pimelic Acid into Biotin by Bacillus sphaericus bioB Transformants&quot;, pp. 121-124, 1992, J. Ferment. Bioeng., vol. 73." scheme="references">
    <meta name="citation_reference" content="Ohsawa et al., Cloning of the Biotin Synthetase Gene from Bacillus sphaericus and Expression in Escherichia coli and Bacilli, pp. 39-48, 1989, Gene, vol. 80." scheme="references">
    <meta name="citation_reference" content="O'Regan et al., &quot;Nucleotide Sequence of the bioH Gene of Escherichia coli&quot;, p. 8004, 1989, Nucleic Acids Research, vol. 17." scheme="references">
    <meta name="citation_reference" content="Otsuka et al., &quot;The Escherichia coli Biotin Biosynthetic Enzyme Sequences Predicted from the Nucleotide Sequence of the bio Operon&quot;, pp. 19577-19585, 1988, J. Biol. Chem., vol. 263, Dec." scheme="references">
    <meta name="citation_reference" content="Ploux et al., &quot;Investigation of the First Step of Biotin Biosynethesis of Bacillus sphaericus&quot;, pp. 685-690, 1992, Biochem. J., vol. 287." scheme="references">
    <meta name="citation_reference" content="Sabatie et al., &quot;Biotin formation by recombinant strains of Escherichia coli: influence of the host physiology&quot;, pp. 29-50, 1991, J. Biotech., vol. 20." scheme="references">
    <meta name="citation_reference" content="Singer et al. (1991) Gene 106, 1-6.*" scheme="references">
    <meta name="citation_reference" content="Studier et al., &quot;Use of Bacteriophage T7 RNA Polymerase to Direct Selective High-Level Expression of Cloned Genes&quot;, pp. 113-130, 1986, J. Mol. Biol., vol. 189." scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Method to produce biotin 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA72603988" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">The pesent invention is directed to biotin-producing recombinant cells transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof, either alone or in combination with at least one additional nucleic acid sequence selected from <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or a functional equivalent of any of these genes. Preferred recombinant cells are capable of converting essentially all biotin vitamers to true biotin. The present invention also provides a method to produce biotin by culturing such recombinant cells under appropriate conditions in an effective medium, which preferably includes biotin precursor supplements. The present invention is also directed to recombinant cells transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof, either alone or with at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, and functional equivalents thereof, said recombinant cells being capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof; and use of such cells to produce biotin.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">23</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/3e/56/fb/8002010dc0d710/US6277609-drawings-page-3.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/09/c6/e6/5dcb6be776ad44/US6277609-drawings-page-4.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/25/92/f4/361943bf012e7d/US6277609-drawings-page-5.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/82/03/be/46cc6be80288dd/US6277609-drawings-page-6.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a1/4c/df/0f74c78b5c77e9/US6277609-drawings-page-7.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/61/ea/2e/4f6d19b299b937/US6277609-drawings-page-8.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/48/06/d0/eb9e8e9fc6aed2/US6277609-drawings-page-9.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/27/4b/a6/f6c75fa4b198f8/US6277609-drawings-page-10.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/5c/eb/ad/46aa7d10f11f7a/US6277609-drawings-page-11.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/98/76/0c/a70faddd08e85c/US6277609-drawings-page-12.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/74/56/6f/1b516fe97f1b42/US6277609-drawings-page-13.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/74/3a/79/e609430bb16573/US6277609-drawings-page-14.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ee/d1/ce/d61e3dde3ce42f/US6277609-drawings-page-15.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c9/c4/33/59b7b06a63d9fa/US6277609-drawings-page-16.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/cb/a7/63/daf0e457971799/US6277609-drawings-page-17.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c1/4e/41/ee441e6138af30/US6277609-drawings-page-18.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c5/a6/cc/611a592d8c8536/US6277609-drawings-page-19.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/59/ac/64/7a925b05ecc248/US6277609-drawings-page-20.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/77/7f/e3/e2335db5d400f3/US6277609-drawings-page-21.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/99/88/3c/70146c9803eb34/US6277609-drawings-page-22.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e2/ab/a2/17ecfd4c96b891/US6277609-drawings-page-23.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b0/dd/1d/8028f098268217/US6277609-drawings-page-24.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/18/7b/1a/237a2068391461/US6277609-drawings-page-25.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/18"><a id="link" href="#" class="style-scope state-modifier">C12P17/18</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/185"><a id="link" href="#" class="style-scope state-modifier">C12P17/185</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12P17/186"><a id="link" href="#" class="style-scope state-modifier">C12P17/186</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/11"><a id="link" href="#" class="style-scope state-modifier">C12N15/11</a></state-modifier>
                  <span class="description style-scope classification-tree">DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/52"><a id="link" href="#" class="style-scope state-modifier">C12N15/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Genes encoding for enzymes or proenzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 1 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Genetics &amp; Genomics"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Genetics &amp; Genomics
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US6277609B1</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent ( no pre-grant publication)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/c7/a7/61/87a62099ea33ae/US6277609.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;col&quot;,&quot;escherichia coli&quot;,&quot;biotin&quot;,&quot;sph&quot;,&quot;gene&quot;]" data-before="19930106"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US6277609B1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Christina K. Eddy"><a id="link" href="#" class="style-scope state-modifier">Christina K. Eddy</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    BASF SE
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1993</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/001,063</div>
                <div class="style-scope application-timeline">Filing date: 1993-01-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US08/001,063 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1993-01-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="BASF SE"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by BASF SE</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="priority style-scope application-timeline">1993-01-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to US08/001,063</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">1993-01-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="ZEAGEN, INC."><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to ZEAGEN, INC.</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST.</div><div class="description-item style-scope application-timeline">Assignors: CAMPBELL, JOHN W., EDDY, CHRISTINA K.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">1993-06-28</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="UNIVERSAL FOODS CORPORATION"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to UNIVERSAL FOODS CORPORATION</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). EFFECTIVE ON 06/17</div><div class="description-item style-scope application-timeline">Assignors: ZEAGEN, INC.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">1994-08-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="BASF AKTIENGESELLSCHAFT"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to BASF AKTIENGESELLSCHAFT</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: UNIVERSAL FOODS CORP.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2001-08-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2001-08-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US6277609B1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2018-08-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Fee Related</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (13)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (18)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (4)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PALL&amp;s1=6277609.PN.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/08001063">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=6277609">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=6277609B1&amp;KC=B1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/patent/US/6277609/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US6277609">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES54714412" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <heading class="style-scope patent-text">FIELD OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">This invention relates to a method for producing biotin using recombinant cells transformed with nucleic acid sequences involved in biotin biosynthesis. In particular, this invention discloses a method to improve the ability of such recombinant cells to convert biotin vitamers to true biotin. The invention also discloses a method for improving over-all biotin production.</div>
    <heading class="style-scope patent-text">BACKGROUND OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">Biotin, or vitamin H, is an indispensable element in intermediary metabolism in many organisms since it is an essential factor of biotin-dependent carboxylases important in fatty acid synthesis, gluconeogenesis, and amino acid metabolism. Biotin is useful as a food supplement, as a cosmetic additive, and as a diagnostic reagent in biotin-avidin-based detection assays.</div>
    <div class="description-paragraph style-scope patent-text">Most biotin for commercial use is currently produced by a complex chemical synthesis process. Although several investigators are attempting to synthesize biotin in commercial quantities using microbiological methods, the cost thus far has been prohibitive. Wild type microorganisms produce only small amounts of the vitamin apparently because such microorganisms exert tight control over biotin biosynthesis. In an effort to improve microbial biotin production, some investigators have transformed microorganisms with <i class="style-scope patent-text">Escherichia coli </i>or <i class="style-scope patent-text">Bacillus sphaericus </i>genes that encode certain proteins involved in the biotin biosynthetic pathway. Although expression of these genes in some cases did increase true biotin and/or biotin vitamer production, the amount of true biotin produced using such methods is substantially lower than that required for a commercially viable process.</div>
    <div class="description-paragraph style-scope patent-text">The biotin biosynthetic pathway in <i class="style-scope patent-text">Escherichia coli </i>is thought to include at least 5 enzymatic steps catalyzed by enzymes encoded by <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioF, bioC, and bioD genes contained on the biotin operon. The <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioD, and bioF genes are thought to encode enzymes having the following respective activities: 7,8-diaminopelargonic acid aminotransferase (also called 7,8-diaminopelargonic acid synthase), biotin synthetase (also called biotin synthase), desthiobiotin synthetase (also called desthiobiotin synthase), and 7-keto-8-aminopelargonic acid synthetase (also called 7-keto-8-aminopelargonic acid synthase). The protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioC gene is thought to operate at an early step in the biotin biosynthetic pathway, but the protein's actual function is presently unknown. The biotin operon also includes an additional open reading frame, referred to as <i class="style-scope patent-text">Escherichia coli </i>ORF 1, the function of which, until the present invention, has been unknown (e.g., Otsuka et al., pp. 19577-19585, 1988, <i class="style-scope patent-text">J. Biol. Chem., </i>vol. 263; Brown et al., pp. 295-326, 1991, <i class="style-scope patent-text">Biotech. Genet. Engineer. Reviews, </i>vol. 9; Eisenberg, pp. 544-550, 1987, in <i class="style-scope patent-text">Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology, </i>Neidhardt, F. C. et al., eds., American Society of Microbiology, Washington, D.C.). In addition, the <i class="style-scope patent-text">Escherichia coli </i>bioH gene, located at a site distant from the biotin operon, encodes a protein thought to be involved in an early, but as yet unknown, step in the biotin biosynthetic pathway (e.g., O'Regan et al., p. 8004, 1989, <i class="style-scope patent-text">Nucleic Acids Res., </i>vol 17; Brown et al., ibid.</div>
    <div class="description-paragraph style-scope patent-text">Two gene clusters encoding enzymes involved in biotin biosynthesis have been isolated from <i class="style-scope patent-text">Bacillus sphaericus. </i>The two gene clusters include the linked <i class="style-scope patent-text">Bacillus sphaericus </i>genes bioD, bioA, bioY, and bioB, also referred to as <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB; and linked <i class="style-scope patent-text">Bacillus sphaericus </i>genes bioX, bioW, and bioF, also referred to as <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF (see, for example, Gloeckler et al., pp. 63-70, 1990, <i class="style-scope patent-text">Gene, </i>vol. 87; U.S. Pat. No. 5,096,823 by Gloeckler et al., issued Mar. 17, 1992; European Patent Office Publication No. 266,240, by Gloeckler et al., published May 4, 1988; and European Patent Publication No. 240,105, by Ohsawa et al., published Nov. 7, 1987). <i class="style-scope patent-text">Bacillus sphaericus </i>and <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioD, and bioF genes are structurally similar and apparently encode functionally equivalent enzymes (e.g., Brown et al., ibid.). <i class="style-scope patent-text">Bacillus sphaericus </i>bioW, bioX and bioY genes, which apparently are not structurally homologous to known <i class="style-scope patent-text">Escherichia coli </i>genes, are thought to be involved in the active uptake of pimelic acid by <i class="style-scope patent-text">Bacillus sphaericus </i>(e.g., Brown et al., ibid.). In contrast, some investigators have hypothesized that uptake of pimelic acid by <i class="style-scope patent-text">Escherichia coli </i>is by passive diffusion (e.g., Brown et al., ibid.; Ploux et al., pp. 685-690, 1992, <i class="style-scope patent-text">Biochem. J., </i>vol. 287).</div>
    <div class="description-paragraph style-scope patent-text">Several investigators have disclosed systems to attempt to express biotin using the <i class="style-scope patent-text">Escherichia coli </i>biotin operon. For example, GB Publication No. 2,216,530, by Pearson et al., published Oct. 11, 1989, discloses expression of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon in <i class="style-scope patent-text">Saccharomyces cerevisiae </i>but does not report biotin production levels. In another example, Fisher, in U.S. Pat. No. 5,110,731, issued May 5, 1992, discloses that a biotin retention-deficient mutant of <i class="style-scope patent-text">Escherichia coli </i>transformed with a plasmid containing the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produced a maximum of 30 milligrams (mg) of biotin per liter of medium.</div>
    <div class="description-paragraph style-scope patent-text">Several researchers (see, for example, Ogata, pp. 390-394, 1970, <i class="style-scope patent-text">Methods in Enzymology, </i>vol. 17a; Izumi et al., pp. 231-256, in <i class="style-scope patent-text">Biotechnology of Vitamins, Pigments, and Growth Factors, </i>Elsevier Applied Science, E. J. Vandamme, ed.; U.S. Pat. No. 3,393,129, by Shibata et al., issued Jul. 16, 1968; and U.S. Pat. No. 4,563,426 by Yamada et al., issued Jan. 7, 1986) have reported that true biotin and biotin vitamer production by fungal and bacterial microorganisms, and in particular by <i class="style-scope patent-text">Bacillus sphaericus, </i>increases when the microorganisms are grown in the presence of biotin precursors, such as pimelic acid and desthiobiotin. Based upon this observation, attempts have been made to increase biotin production by transforming <i class="style-scope patent-text">Escherichia coli </i>and <i class="style-scope patent-text">Bacillus sphaericus </i>microorganisms with either the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene or <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB and bioXWF biotin gene clusters and growing the transformants in the presence of biotin precursors.</div>
    <div class="description-paragraph style-scope patent-text">European Patent Publication No. 375,525, by Gloeckler et al., published Jun. 27, 1990, discloses the use of <i class="style-scope patent-text">Escherichia coli </i>host cells transformed with the two clusters of <i class="style-scope patent-text">Bacillus sphaericus </i>biotin operon genes (i.e., bioDAYB and bioXWF) to produce biotin. When such transformed hosts were grown in medium containing pimelic acid, they produced 144-160 mg of biotin vitamers per liter of medium but only 15-16 mg of true biotin per liter of medium. Thus, the amount of true biotin produced was only about 9 to 10 percent of the amount of total biotin (i.e., true biotin and vitamers) produced, indicating that, despite a high gene copy number, the transformed cells could not completely convert the biotin vitamers to true biotin. In addition, of the total amount of biotin vitamers produced, only 25 percent to 28 percent was desthiobiotin (the direct precursor of biotin), suggesting that about 70 percent of the biotin vitamers produced were compounds that had yet to be converted to desthiobiotin.</div>
    <div class="description-paragraph style-scope patent-text">Sabatié et al., pp.29-50, 1991, <i class="style-scope patent-text">Journal of Biotechnology, </i>vol. 20, also transformed <i class="style-scope patent-text">Escherichia coli </i>cells with a vector containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB and bioXWF gene clusters. When such transformed cells were grown in the presence of pimelic acid under fed-batch fermentation conditions, the cells produced 300 mg of biotin vitamers per liter of medium, but only 45 mg of true biotin per liter of medium. Thus, the amount of true biotin produced by Sabatié et al. was only 13 percent of the total amount of biotin (i.e., true biotin and vitamers) produced, again indicating inefficient conversion of biotin vitamers to true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Ohsawa et al., pp. 39-48, 1989, <i class="style-scope patent-text">Gene, </i>vol. 80, transformed <i class="style-scope patent-text">Escherichia coli, Bacillus sphaericus </i>and <i class="style-scope patent-text">Bacillus subtilis </i>with vectors containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene under the control of suitable promoters. Transformed strains were grown in medium containing desthiobiotin. Biotin production by <i class="style-scope patent-text">Escherichia coli </i>and <i class="style-scope patent-text">Bacillus subtilis </i>cells transformed with plasmids containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene was about 1500-fold higher than biotin production by cells transformed with plasmids lacking the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene. Biotin production by <i class="style-scope patent-text">Bacillus sphaericus </i>cells transformed with plasmids containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene was about 100-fold higher than biotin production by cells transformed with plasmids lacking the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene.</div>
    <div class="description-paragraph style-scope patent-text">Ohsawa et al., pp. 121-124, 1992, <i class="style-scope patent-text">J. Ferment. Bioeng., </i>vol. 73, also cultured <i class="style-scope patent-text">Bacillus sphaericus </i>cells transformed with a plasmid containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene in medium containing pimelic acid. Cells transformed with a plasmid lacking the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene made less than 0.2 mg of true biotin per liter of medium and about 25 mg of vitamers and true biotin per liter of medium. Cells transformed with a plasmid containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene made about 1.2-3.5 mg of true biotin per liter of medium and about 30 mg of vitamers and true biotin per liter of medium. Thus, despite the increased expression of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene, only 4 percent to 10.4 percent of the total amount of biotin (i.e., biotin vitamers and true biotin) produced was true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Additional attempts to increase biotin production have included efforts to obtain hosts that are derepressed for biotin synthesis (see, for example, Japanese Patent Publication No. 62,155,081, assigned to Shiseido KK, published Jul. 10, 1987; Japanese Patent Publication No. 61,202,686, assigned to Shiseido KK, published Sep. 8, 1986; Japanese Patent Publication No. 61,149,091, assigned to Nippon Soda KK, published Jul. 7, 1986; and European Patent Publication No. 379,442, by Gloeckler et al., published Jul. 25, 1990), and to obtain low-acetate synthesizing mutants (see, for example, European Patent Publication No. 316,229, by Haze et al., published May 17, 1989). However, none of these techniques has led to the production of commercially significant amounts of true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Thus there remains both a need to improve overall biotin production by amplifying expression of additional genes in the biotin biosynthetic pathway and to improve production of true biotin by engineering cells to convert biotin vitamers to true biotin.</div>
    <heading class="style-scope patent-text">SUMMARY OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">The present invention is directed to a method to produce biotin in which biotin vitamers are efficiently converted into true biotin by transforming host cells with nucleic acid sequences encoding enzymes involved in biotin biosynthesis. For example, cells transformed with at least an <i class="style-scope patent-text">Escherichia coli </i>bioH gene or functional equivalent thereof can produce increased amounts of biotin. Additionally, unprecedented yields of true biotin, particularly due to increased conversion of biotin vitamers to true biotin, can be obtained by culturing, in an effective medium, cells transformed with at least an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or functional equivalent thereof.</div>
    <div class="description-paragraph style-scope patent-text">The present invention includes a biotin-producing recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof, either alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or functional equivalents thereof (i.e., a functional equivalent of any of the aforementioned genes or nucleic acid sequences). Preferably, recombinant cells of the present invention are bacterial or yeast cells; preferably of the genus Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, or Saccharomyces; more preferably of the species <i class="style-scope patent-text">Escherichia coli, Bacillus sphaericus, </i>or <i class="style-scope patent-text">Bacillus subtilis; </i>and even more preferably of the species <i class="style-scope patent-text">Escherichia coli. </i>Recombinant cells are preferably produced by transforming recombinant molecules of the present invention into host cells. Recombinant molecules of the present invention are formed by operatively linking nucleic acid sequences of the present invention to expression vectors containing at least one transcription control sequence functional in the respective cell to be transformed. Particularly preferred transcription control sequences include bacteriophage T7 transcription control sequences.</div>
    <div class="description-paragraph style-scope patent-text">The present invention further relates to a recombinant cell, other than <i class="style-scope patent-text">Escherichia coli, </i>transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof. Such a recombinant cell, preferably of the genus Bacillus, can also be transformed with at least one nucleic acid sequence selected from the group consisting of <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioF, and bioH genes, and functional equivalents of any of such genes.</div>
    <div class="description-paragraph style-scope patent-text">One aspect of the present invention is the use of recombinant cells of the present invention to produce biotin by culturing such cells under appropriate conditions in a medium effective for the production of biotin, and recovering biotin therefrom. Preferably, the effective medium is supplemented with at least one biotin precursor, or derivative thereof, which can be efficiently converted to true biotin by the recombinant cell, thereby increasing the amount of true biotin produced by the recombinant cell. Preferred supplements include dicarboxylic acids, such as pimelic acid and azelaic acid; biotin vitamers; derivatives thereof; and mixtures thereof. A particularly preferred biotin precursor supplement is a compound that is produced by a reaction in the biotin biosynthetic pathway occurring prior to the reactions carried out by enzymes encoded by the genes transformed into the recombinant cell being cultured. For example, a particularly preferred effective medium for a recombinant cell transformed with <i class="style-scope patent-text">Escherichia coli </i>bioE, and <i class="style-scope patent-text">Bacillus sphaericus </i>bioB, bioD, bioA, bioF, bioW, bioX, and bioY genes, or functional equivalents thereof, is a medium supplemented with pimelic acid or a derivative thereof. A particularly preferred effective medium for a recombinant cell transformed with <i class="style-scope patent-text">Escherichia coli </i>bioE, and <i class="style-scope patent-text">Bacillus sphaericus </i>bioB, bioD, and bioA, or functional equivalents thereof, is a medium supplemented with 2-keto-8-aminopelargonic acid or a derivative thereof. A particularly preferred effective medium for a recombinant cell transformed with <i class="style-scope patent-text">Escherichia coli </i>bioE, and <i class="style-scope patent-text">Bacillus sphaericus </i>bioB, and bioD, or functional equivalents thereof, is a medium supplemented with 7,8-diaminopelargonic acid or a derivative thereof.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cells of the present invention are especially useful for their ability to efficiently convert biotin vitamers to true biotin. When cultured in an effective medium, such cells are capable of producing biotin such that at least about 25 percent of the total biotin (i.e., true biotin and biotin vitamers) produced is true biotin. Preferably at least about 50 percent, more preferably at least about 75 percent, and even more preferably at least about 90 percent, of the total biotin produced using such cells is true biotin. Particularly preferred recombinant cells produce essentially about 100 percent true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Another aspect of the present invention is a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof, such a recombinant cell being capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof. The recombinant cell can also be transformed with at least one nucleic acid sequence selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, and functional equivalents thereof.</div>
    <div class="description-paragraph style-scope patent-text">The present invention also includes recombinant molecules containing an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof, either alone or with at least one of the aforementioned nucleic acid sequences; a method to produce such a recombinant cell; and use of such a cell to produce biotin by culturing the cell in an effective medium and recovering biotin produced thereby.</div>
    
    
    <heading class="style-scope patent-text">BRIEF DESCRIPTION OF FIGURES</heading>
    <div class="description-paragraph style-scope patent-text">FIG. 1 is a schematic illustration of the enzymatic steps believed to be involved in the <i class="style-scope patent-text">Escherichia coli </i>biotin biosynthetic pathway.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 2 contains a schematic drawing of the process of constructing plasmids containing genes of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text">FIGS. 3 through 9 contain schematic drawings of methods to produce certain nucleic acid sequences and recombinant molecules containing <i class="style-scope patent-text">Escherichia coli </i>genes encoding enzymes involved in biotin production.</div>
    <div class="description-paragraph style-scope patent-text">FIGS. 10 through 15 contain schematic drawings of methods to produce certain nucleic acid sequences containing <i class="style-scope patent-text">Bacillus sphaericus </i>genes and certain recombinant molecules containing <i class="style-scope patent-text">Escherichia coli </i>and <i class="style-scope patent-text">Bacillus sphaericus </i>genes encoding enzymes involved in biotin production.</div>
    <div class="description-paragraph style-scope patent-text">FIGS. 16 and 17 illustrate a time course of biotin production by certain recombinant cells of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">FIGS. 18 through 22 contain schematic drawings of methods to produce additional nucleic acid sequences and recombinant molecules containing <i class="style-scope patent-text">Escherichia coli </i>genes encoding enzymes involved in biotin production.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 23 illustrates a time course of biotin production by additional recombinant cells of the present invention.</div>
    
    
    <heading class="style-scope patent-text">DETAILED DESCRIPTION OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">One aspect of the present invention is directed to a method to efficiently convert biotin vitamers to true biotin by introducing into a cell a gene that, until now, had not been recognized for its importance in biotin biosynthesis. Use of such a gene is particularly applicable to microorganisms which tend to accumulate biotin vitamers, such as but not limited to 7-keto-8-aminopelargonic acid and 7,8-diaminopelargonic acid. As used herein, the terms “biotin” and “total biotin” include the entire spectrum of biotin and biotin vitamer molecules that can be utilized by <i class="style-scope patent-text">Saccharomyces cerevisiae </i>(see, for example, Ogata et al., pp. 889-894, 1965, <i class="style-scope patent-text">Agr. Biol. Chem., </i>vol. 29). As such, “biotin” and “total biotin” include both biotin vitamers and true biotin. As used herein, the term “true biotin” refers to a compound having the chemical structure of vitamin H, as well as any compound that shares substantial functional attributes and characteristics thereof. True biotin molecules are capable of supporting the growth of <i class="style-scope patent-text">Lactobacillus arabinosus </i>(see, for example, Ogata et al., ibid). As used herein, the term “biotin vitamers” include those vitamers that are utilized by <i class="style-scope patent-text">Saccharomyces cerevisiae </i>but that do not support the growth of <i class="style-scope patent-text">Lactobacillus arabinosus. </i> </div>
    <div class="description-paragraph style-scope patent-text">One embodiment of the present invention is the identification of <figure-callout id="1" label="ORF" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF</a></figure-callout> 1 of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon as a gene encoding a key enzyme in the biotin biosynthetic pathway. This gene, referred to in the present application as the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, encodes desthiobiotin synthetase activity, an enzyme previously thought to be encoded by the bioD gene. The present invention shows, for example, that cells transformed with <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioF, bioC, and bioD genes, or with <i class="style-scope patent-text">Bacillus sphaericus </i>bioB, bioD, bioA, bioF, bioW, bioX, and bioY genes, produce primarily biotin vitamers unless such cells are also transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof. Thus, the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, can be used to improve biotin production, and particularly the conversion of biotin vitamers to true biotin, in a number of microorganisms as disclosed hereinafter. The inventors believe that, even though a large amount of research has been conducted on the various genes and enzymes of the biotin biosynthetic pathway, the function of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene has remained unappreciated.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, reference to a “gene” means the natural gene itself as well as any functionally equivalent nucleic acid sequences thereof, including, but not limited to, insertions, substitutions, deletions and/or inversions of nucleotides which have substantially no effect on the primary functional characteristics of the product encoded by the gene. A functional equivalent of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, therefore, is any gene which encodes an enzyme having an essentially similar activity as the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene (i.e., any gene which encodes an active desthiobiotin synthetase). A functional equivalent of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene can be isolated from any biotin-producing organism, such as, but not limited to, <i class="style-scope patent-text">Bacillus sphaericus, Bacillus subtilis, </i>other bacteria, and yeast. A functional equivalent of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene also includes nucleic acid sequences containing, for example, nucleotide deletions, additions, substitutions, and/or inversions that do not substantially interfere with the nucleic acid sequence's ability to encode an enzyme capable of desthiobiotin synthetase activity.</div>
    <div class="description-paragraph style-scope patent-text">Use of an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof is particularly effective when the gene is co-expressed with the <i class="style-scope patent-text">Bacillus sphaericus </i>biotin operon gene clusters bioDAYB and bioXWF, since overexpression of the <i class="style-scope patent-text">Bacillus sphaericus </i>gene clusters in either <i class="style-scope patent-text">Bacillus sphaericus </i>or <i class="style-scope patent-text">Escherichia coli </i>without the bioE gene leads predominantly to the production of biotin vitamers rather than of true biotin. According to the present invention, high levels of expression of the bioE gene concomitant with high levels of expression of the <i class="style-scope patent-text">Bacillus sphaericus </i>biotin gene clusters or functional equivalents thereof, increases conversion of biotin vitamers to true biotin, thereby improving true biotin production.</div>
    <div class="description-paragraph style-scope patent-text">The function of the protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, as identified by the inventors, can be determined using a number of different methods. Such methods include genetic manipulation of genes encoding enzymes involved in biotin biosynthesis and phenotypic complementation assays.</div>
    <div class="description-paragraph style-scope patent-text">One aspect of the present invention is the isolation and manipulation of DNA fragments containing either the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon or portions thereof in order to determine the function of the protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene. The <i class="style-scope patent-text">Escherichia coli </i>biotin operon can be isolated using standard techniques described in detail by Sambrook et al., <i class="style-scope patent-text">Molecular Cloning: A Laboratory Manual, </i>Cold Spring Harbor Labs Press, 1989, which is incorporated herein by reference in its entirety. Expression vectors are constructed that contain the <i class="style-scope patent-text">Escherichia coli </i>biotin operon genes bioA, bioB, bioF, bioC, and bioD, with or without the bioE gene. These constructs are referred to, respectively, as pAEBFCD and pABFCD. For example, in one embodiment of the present invention, the biotin operon genes comprising pAEBFCD and pABFCD are placed in pDIP18 expression vectors to form pDIPAEBFCD and pDIPABFCD, respectively, in which expression of the genes is controlled by the bacteriophage T7 promoter. In another embodiment, the biotin operon genes comprising pAEBFCD and pABFCD are placed in pUC18 expression vectors to form pUCAEBFCD and pUCABFCD, respectively.</div>
    <div class="description-paragraph style-scope patent-text">The function of the protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene can be analyzed by transforming <i class="style-scope patent-text">Escherichia coli </i>cells with either pAEBFCD or pABFCD and culturing the resultant transformed cells in a medium effective to promote biotin production (e.g., LB broth). Following culturing, total biotin, true biotin, and biotin vitamer production levels can be measured in a variety of ways known to one skilled in the art including, but not limited to, microbiological, chromatographic, and chemical assays. Cells transformed with pABFCD produce mostly biotin vitamers, whereas cells transformed with pAEBFCD produce mostly true biotin. Thus, the <i class="style-scope patent-text">Escherichia coli </i>bioE gene appears to encode a protein that is important in the conversion of biotin vitamers to true biotin.</div>
    <div class="description-paragraph style-scope patent-text">The function of the protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene can also be determined using phenotypic complementation assays. For example, cross-feeding studies can be used to determine if the <i class="style-scope patent-text">Escherichia coli </i>bioE gene can restore biotin production in individual biotin auxotrophs. Separate plates containing biotin-free nutrient agar (e.g., M9 minimal medium containing vitamin-free amino acids, thiamine, and agar) are streaked with either <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> or <i class="style-scope patent-text">Escherichia coli </i>bioB<sup class="style-scope patent-text">−</sup> cells. The plates are then cross-streaked with the following <i class="style-scope patent-text">Escherichia coli </i>strains: bioD<sup class="style-scope patent-text">−</sup> cells, bioB<sup class="style-scope patent-text">−</sup> cells, bioC<sup class="style-scope patent-text">−</sup> cells, bioF<sup class="style-scope patent-text">−</sup> cells, bioA<sup class="style-scope patent-text">−</sup> cells, cells lacking the biotin operon (e.g., <i class="style-scope patent-text">Escherichia coli </i>SA291 cells) that have been transformed with pAEBFCD (e.g., <i class="style-scope patent-text">Escherichia coli </i>SA291-pUCAEBFCD cells); or cells lacking the biotin operon (e.g., <i class="style-scope patent-text">Escherichia coli </i>SA291 cells) that have been transformed with pABFCD (e.g., <i class="style-scope patent-text">Escherichia coli </i>SA291-pUCABFCD cells). The ability of <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> or bioB<sup class="style-scope patent-text">−</sup> cells to cross-feed each strain is determined by visual inspection. <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> cells were found to be incapable of cross-feeding <i class="style-scope patent-text">Escherichia coli </i>bioB<sup class="style-scope patent-text">−</sup> cells or <i class="style-scope patent-text">Escherichia coli </i>SA291-pABFCD cells. <i class="style-scope patent-text">Escherichia coli </i>bioB<sup class="style-scope patent-text">−</sup> cells, however, were capable of cross-feeding SA291-pABFCD cells and bioD<sup class="style-scope patent-text">−</sup> cells. Both <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> and bioB<sup class="style-scope patent-text">−</sup> cells were able to cross-feed bioC<sup class="style-scope patent-text">−</sup>, bioF<sup class="style-scope patent-text">−</sup>, and bioA<sup class="style-scope patent-text">−</sup> cells. Thus, referring to FIG. 1, it is apparent that the <i class="style-scope patent-text">Escherichia coli </i>bioE gene encodes an enzyme active in the biotin biosynthesis pathway prior to the activity of the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioB gene and following the activity of the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioD gene.</div>
    <div class="description-paragraph style-scope patent-text">That the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene has desthiobiotin synthetase activity is supported by the finding that the <i class="style-scope patent-text">Escherichia coli </i>bioE gene encodes an enzyme that catalyzes the production of a compound that has properties characteristic of desthiobiotin, such as stability and ability to combine with avidin. In contrast, the compound produced in a reaction catalyzed by the <i class="style-scope patent-text">Escherichia coli </i>bioD gene product is labile and is not capable of binding to avidin.</div>
    <div class="description-paragraph style-scope patent-text">One embodiment of the present invention is a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, alone or in combination with at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, and functional equivalents thereof. Preferably, the recombinant cell is cultured in an effective medium so as to produce biotin such that at least about 25 percent of the aggregate production of true biotin and biotin vitamers by the cell is true biotin. As used herein, a “functional equivalent” of a particular nucleic acid sequence (e.g., a gene) is a nucleic acid sequence that encodes a protein having substantially the same biological function as the protein encoded by the particular nucleic acid sequence. It is within the scope of the present invention to isolate and use a functionally equivalent nucleic acid sequence obtained or derived from any biotin-producing microorganism. For example, functional equivalents of a <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene include nucleic acid sequences isolated from any biotin-producing microorganism that encode an enzyme with biotin synthetase activity. Thus, a functional equivalent of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene can be an <i class="style-scope patent-text">Escherichia coli </i>bioB gene.</div>
    <div class="description-paragraph style-scope patent-text">In addition, functionally equivalent nucleic acid sequences can include nucleic acid sequences containing modifications, such as nucleotide deletions, additions, substitutions, and/or inversions that do not substantially interfere with the nucleic acid sequence's ability to encode a biologically active enzyme. That is, functionally equivalent nucleic acid sequences of the present invention encode enzymes having a biological activity similar to their natural counterparts. Functionally equivalent eukaryotic nucleic acid sequences can also include intervening and/or untranslated sequences surrounding and/or within the coding regions of the nucleic acid sequences.</div>
    <div class="description-paragraph style-scope patent-text">A functionally equivalent nucleic acid sequence can be obtained using methods known to those skilled in the art (see, for example, Sambrook et al., ibid.). For example, nucleic acid sequences can be modified using a variety of techniques including, but not limited to, classic mutagenesis techniques and recombinant DNA techniques, such as site-directed mutagenesis, chemical treatment of a nucleic acid to induce mutations, restriction enzyme cleavage of a nucleic acid fragment, ligation of nucleic acid fragments, polymerase chain reaction (PCR) amplification and/or mutagenesis of selected regions of a nucleic acid sequence, synthesis of oligonucleotide mixtures and ligation of mixture groups to “build” a mixture of nucleic acid sequences, and combinations thereof. Functionally equivalent nucleic acids can be selected from a mixture of modified nucleic acid sequences by screening for the function of the protein encoded by the nucleic acid sequence. A number of screening techniques are known to those skilled in the art including, but not limited to, complementation assays, binding assays, and enzyme assays. In one embodiment, a nucleic acid sequence that is functionally equivalent to the <i class="style-scope patent-text">Escherichia coli </i>bioE gene can be selected by its ability to complement an <i class="style-scope patent-text">Escherichia coli </i>strain that lacks a functional bioE gene. For example, a nucleic acid sequence functionally equivalent to the <i class="style-scope patent-text">Escherichia coli </i>bioE gene from a bacterial or yeast strain can be selected by transforming a microorganism (preferably <i class="style-scope patent-text">Escherichia coli</i>) that lacks a functional bioE gene with a genomic library prepared from that strain and isolating nucleic acid sequences that enable such a microorganism to grow in the absence of biotin.</div>
    <div class="description-paragraph style-scope patent-text">Nucleic acid sequences of the present invention can be from any biotin-producing cell, such as but not limited to any bacterial, yeast, other fungal, insect, animal, or plant cell that produces biotin. Bacterial and yeast cells are preferred sources of nucleic acid sequences. More preferred sources are Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, or Saccharomyces, with <i class="style-scope patent-text">Escherichia coli, Bacillus sphaericus, </i>and <i class="style-scope patent-text">Bacillus subtilis, </i>being more preferred. Particularly preferred nucleic acid sequences of the present invention are the bioA, bioB, bioC, bioD, bioE, bioF, and bioH genes of <i class="style-scope patent-text">Escherichia coli </i>and the bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes of <i class="style-scope patent-text">Bacillus sphaericus. </i> </div>
    <div class="description-paragraph style-scope patent-text">A preferred recombinant cell of the present invention is a cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, alone or in combination with at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, and functional equivalents thereof, such that at least one of the nucleic acid sequences is a <i class="style-scope patent-text">Bacillus sphaericus </i>nucleic acid sequence (i.e., it has the nucleic acid sequence of a <i class="style-scope patent-text">Bacillus sphaericus </i>nucleic acid sequence). Preferably, such a recombinant cell is not transformed with a nucleic acid sequence containing the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon (e.g., the HindIII/EcoRI restriction fragment found in lambda bio-transducing phage bioT124; Guha et al., pp. 53-62, 1971, <i class="style-scope patent-text">J. Mol. Biol., </i>Vol. 56), especially if the cell is cultured in an effective medium supplemented with pimelic acid, or a derivative thereof, to produce biotin.</div>
    <div class="description-paragraph style-scope patent-text">Preferred combinations of nucleic acid sequences with which to transform a host cell include the <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof (denoted E herein) in combination with at least one of the following nucleic acid sequences: (a) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene or a functional equivalent thereof (denoted B herein); (b) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioD gene or a functional equivalent thereof (denoted D herein); (c) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioA gene or a functional equivalent thereof (denoted A herein); (d) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioF gene or a functional equivalent thereof (denoted F herein); (e) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioW gene or a functional equivalent thereof (denoted W herein); (f) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioX gene or a functional equivalent thereof (denoted X herein); and (g) a <i class="style-scope patent-text">Bacillus sphaericus </i>bioY gene or a functional equivalent thereof (denoted Y herein). These nucleic acid sequences can be transformed into the host cell on one or more recombinant molecules, as described further hereinafter.</div>
    <div class="description-paragraph style-scope patent-text">Another embodiment of the present invention is a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene or functional equivalent thereof (denoted H herein) alone or in combination with at least one of the following nucleic acid sequences: (a) an <i class="style-scope patent-text">Escherichia coli </i>bioB gene or a functional equivalent thereof (denoted B, as above, since <i class="style-scope patent-text">Escherichia coli </i>bioB and <i class="style-scope patent-text">Bacillus sphaericus </i>bioB genes are functional equivalents); (b) an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof (denoted E herein); (c) an <i class="style-scope patent-text">Escherichia coli </i>bioD gene or a functional equivalent thereof (denoted D herein); (d) an <i class="style-scope patent-text">Escherichia coli </i>bioA gene or a functional equivalent thereof (denoted A herein); (e) an <i class="style-scope patent-text">Escherichia coli </i>bioF gene or a functional equivalent thereof (denoted F herein); and (f) an <i class="style-scope patent-text">Escherichia coli </i>bioC gene or a functional equivalent thereof (denoted C herein). These nucleic acid sequences can be transformed into the host cell on one or more recombinant molecules, as described further hereinafter. Preferably, a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof, is capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof.</div>
    <div class="description-paragraph style-scope patent-text">Preferred nucleic acid sequence combinations using genes and nucleic acid sequences with the aforementioned notations include, but are not limited to, E, EB, EBD, EBDA, EBDAF, EBDAFWXY, H, BH, EH, BEH, BEDH, BEDAH, BEDAFH, and BEDAFCH. Note that the order of the denoted genes/nucleic acid sequences as presented is not limited to that order but can be any permutation thereof. In addition, the genes/nucleic acid sequences can be introduced into cells on one or more recombinant molecules. While it is critical that the genes and nucleic acid sequences of the present invention be expressed into functional proteins, the method and sequence by which the genes/nucleic acid sequences are introduced into a cell are not critical. Furthermore, each of the denoted genes/nucleic acid sequences can be isolated from any biotin-producing microorganism. In one preferred embodiment of the present invention, E, C, and H genes are isolated from <i class="style-scope patent-text">Escherichia coli </i>and B, D, A, F, W, X, and Y genes are isolated from <i class="style-scope patent-text">Bacillus sphaericus. </i>In a second preferred embodiment, E, B, D, A, F, C, and H genes are isolated from <i class="style-scope patent-text">Escherichia coli </i>and W, X, and Y genes are isolated from <i class="style-scope patent-text">Bacillus sphaericus. </i> </div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred combinations of <i class="style-scope patent-text">Escherichia coli </i>and <i class="style-scope patent-text">Bacillus sphaericus </i>nucleic acid sequences with which to transform cells in order to improve biotin production, and particularly true biotin production are summarized in Table 1. Table 1 uses the aforementioned notations in that the capital letters E, B, D, A, F, C, H, W, X, and Y denote bioE, bioB, bioD, bioA, bioF, bioC, bioH, bioW, bioX, and bioY genes, respectively (e.g., E represents bioE). The term “<sup class="style-scope patent-text">col</sup>” indicates nucleic acid sequences that are isolated from <i class="style-scope patent-text">Escherichia coli </i>cells (e.g., E<sup class="style-scope patent-text">col </sup>is a bioE gene from <i class="style-scope patent-text">Escherichia coli</i>) and “<sup class="style-scope patent-text">sph</sup>” indicates nucleic acid sequences isolated from <i class="style-scope patent-text">Bacillus sphaericus </i>cells. The order of the genes is illustrative and can be any permutation thereof. It will also be understood that while Table 1 specifically denotes the genus and species from which particular genes are derived, the present invention encompasses all functional equivalents of such genes and combinations thereof.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00001" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="1" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <thead valign="bottom" class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="1" morerows="0" rowsep="1" valign="top" class="description-td style-scope patent-text" colspan="1">TABLE 1</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="1" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="1"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Preferred Combinations of Nucleic Acid Sequences</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">with which to Transform Cells</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="1" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="1"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
            
          </tbody></table>
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">B<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td namest="OFFSET" nameend="1" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="2"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">The present invention includes recombinant molecules containing the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, operatively linked to an expression vector comprising one or more transcription control sequences. Recombinant molecules of the present invention can also include at least one nucleic acid sequence selected from <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or a functional equivalent of any of these genes, operatively linked to one or more transcription control sequences.</div>
    <div class="description-paragraph style-scope patent-text">Another embodiment includes recombinant molecules containing the <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or a functional equivalent thereof, operatively linked to an expression vector comprising one or more transcription control sequences. Such recombinant molecules can also include at least one nucleic acid sequence selected from <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, or a functional equivalent of any of these genes, operatively linked to one or more transcription control sequences.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecules of the present invention can contain one or more nucleic acid sequences of the present invention. For example, to transform a cell with the nucleic acid sequence combination E<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>, one can transform the cell with: a single recombinant molecule containing E<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>; with two recombinant molecules in which the first recombinant molecule contains a nucleic acid sequence E<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and the second recombinant molecule contains a nucleic acid sequence X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>; or with multiple recombinant molecules containing other combinations of the nucleic acid sequences.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, the phrase “operatively linked” refers to insertion of a nucleic acid sequence into an expression vector in a manner such that the sequence is able to be expressed when transformed into a host cell. As used herein, an expression vector is a DNA or RNA vector that is capable of transforming a host cell, of replicating within the host cell, and of effecting expression of a specified nucleic acid sequence. Expression vectors can be either prokaryotic or eukaryotic, and are typically viruses or plasmids. Preferred expression vectors of the present invention can include, but are not limited to, any vectors that direct gene expression in bacterial and/or yeast host cells. More preferred expression vectors can direct gene expression in cells of the genus Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, and/or Saccharomyces. Even more preferred expression vectors direct gene expression in cells of the species <i class="style-scope patent-text">Escherichia coli, Bacillus sphaericus, </i>and/or <i class="style-scope patent-text">Bacillus subtilis. </i>Particularly preferred expression vectors are those that function (e.g., direct gene expression) in <i class="style-scope patent-text">Escherichia coli, </i>such as pDIP18, pUC18, and pCKR101 expression vectors.</div>
    <div class="description-paragraph style-scope patent-text">Nucleic acid sequences of the present invention can be operatively linked to expression vectors containing regulatory sequences such as promoters, operators, repressors, enhancers, termination sequences, origins of replication, and other regulatory sequences that are compatible with the host cell and that control the expression of the nucleic acid sequences. In particular, expression vectors of the present invention include transcription control sequences. Transcription control sequences are sequences which control the initiation, elongation, and termination of transcription. Particularly important transcription control sequences are those which control transcription initiation, such as, but not limited to, promoter, enhancer, operator and repressor sequences. Preferred transcription control sequences include, but are not limited to, any transcription control sequences that are able to control transcription in bacteria and/or yeast. More preferred transcription control sequences include those which function in Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, and/or Saccharomyces. Even more preferred transcription control sequences include, but are not limited to, tac, lac, trp, trc, oxy-pro, lambda, bacteriophage T7, bacteriophage T3, bacteriophage SP6, bacteriophage SP01, metallothionein (e.g., CUP1), alpha mating factor, and Pichia alcohol oxidase transcription control sequences. Even more preferred transcription control sequences are bacteriophage T7, tac, and lac transcription control sequences. One preferred expression vector is pCKR101 (Magnuson et al., pp. 262-266, 1992, <i class="style-scope patent-text">FEBS Letters, </i>vol. 299) contains a tac transcription control sequence. Another preferred expression vector, pUC18 (available from GIBCO BRL, Gaithersburg, Md.), contains a lac transcription control sequence. Both tac and lac transcription control sequences contain an operator sequence that is regulated by the lac repressor. Thus, expression from any of these expression vectors can be induced by, for example, isopropyl-β-D-thiogalactoside (IPTG). Yet another preferred expression vector is pDIP18 (obtained from Dr. L. Gold, University of Colorado, Boulder, Colo.). pDIP18 contains a bacteriophage T7 promoter, which is recognized essentially only by bacteriophage T7 RNA polymerase.</div>
    <div class="description-paragraph style-scope patent-text">It is within the scope of the present invention that transcription control sequences can include both nucleic acid sequences, such as promoters, operators, and enhancers, as well as genes encoding RNA polymerases that recognize and initiate transcription from such signals, and genes encoding repressors that interact with the operators. For example, a bacteriophage T7 promoter and a gene encoding a bacteriophage T7 polymerase may be contained either on a plasmid or integrated into the host genome. As an illustrative example, pDIP18, which contains a bacteriophage T7 promoter, can be transformed into a cell in which a gene encoding a bacteriophage T7 RNA polymerase operatively linked to an IPTG-inducible transcription control sequence has been integrated into the cell's chromosomal DNA.</div>
    <div class="description-paragraph style-scope patent-text">Transcription control sequences of the present invention can include naturally occurring transcription control sequences previously associated with a nucleic acid sequence prior to isolation. For example, such transcription control sequences can include sequences associated with genes encoding enzymes involved in biotin biosynthesis. Since such transcription control sequences are usually subject to biotin regulation, such sequences are preferably used in cells in which biotin biosynthesis is deregulated (e.g., cells in which biotin production is no longer repressed by high concentrations of biotin, or by precursors or analogs thereof).</div>
    <div class="description-paragraph style-scope patent-text">According to the present invention, nucleic acid sequences encoding one or more enzymes involved in biotin biosynthesis can be linked (a) individually, (b) as a group, or (c) as a combination thereof to transcription control sequences. The transcription control sequences can be identical or different for the different genes/nucleic acid sequences of the present invention. For example, all desired genes can be linked to a single transcription control sequence or some of the genes can be linked to one transcription control sequence and other genes to a second transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">A recombinant molecule of the present invention can be any nucleic acid sequence combination heretofore described operatively linked to any transcription control sequence capable of effectively regulating expression of the nucleic acid sequence in the cell to be transformed. Preferred recombinant molecules contain the nucleic acid sequence combinations E, EB, EBD, EBDA, EBDAF, EBDAFWXY, H, BH, EH, BEH, BEDH, BEDAH, BEDAFH, and BEDAFCH operatively linked to at least one transcription control sequence, and preferably to at least one bacteriophage T7, tac, and/or lac transcription control sequence. In all cases, the order of the genes is illustrative and can be any permutation thereof. More preferred recombinant molecules contain the nucleic acid sequence combinations described in Table 1 operatively linked to one or more transcription control sequences. Such nucleic acid sequences preferably are operatively linked to an expression vector containing a tac transcription control sequence (e.g., pCKR101), to an expression vector containing a lac transcription control sequence (e.g., pUC18), or, more preferably, to an expression vector containing a bacteriophage T7 transcription control sequence (e.g., pDIP18) for expression in <i class="style-scope patent-text">Escherichia coli </i>cells, and to a bacteriophage SP01 transcription control sequence for expression in Bacillus cells. Even more preferred combinations of recombinant molecules contain the nucleic acid sequences E<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, H<sup class="style-scope patent-text">col</sup>, or E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col </sup>operatively linked to a bacteriophage T7, tac, or lac transcription control sequence, and preferably to a bacteriophage T7 transcription control sequence. Even more preferred recombinant molecules contain the nucleic acid sequences E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, or E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col </sup>operatively linked to at least one transcription control sequence. In all cases, the order of the genes is illustrative and can be any permutation thereof. Particularly preferred recombinant molecules include pDIPE<sup class="style-scope patent-text">col</sup>, pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, pCKRH<sup class="style-scope patent-text">col</sup>, pCKRH′<sup class="style-scope patent-text">col</sup>, pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>.</div>
    <div class="description-paragraph style-scope patent-text">It is within the scope of the present invention that a cell can be transformed with a combination of recombinant molecules that together include all the genes necessary to improve biotin production. For example, a preferred combination of recombinant molecules are the nucleic acid sequences E<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup>each operatively linked to a bacteriophage T7, tac, and/or lac transcription control sequence. A second preferred combination of recombinant molecules are the nucleic acid sequences D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup>each operatively linked to a bacteriophage T7, tac, and/or lac transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">According to one embodiment of the present invention, a recombinant cell is formed by transforming a host cell with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Bacillus sphaericus </i>genes bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or a functional equivalent of any of these genes. According to another embodiment, a recombinant cell is formed by transforming a host cell with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or a functional equivalent thereof, alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, or a functional equivalent of any of these genes.</div>
    <div class="description-paragraph style-scope patent-text">A host cell of the present invention can be either an untransformed cell or a cell that has been previously transformed with a nucleic acid sequence. Thus, the present invention can include transformation of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene into strains of microorganisms previously transformed with at least one other nucleic acid sequence encoding an enzyme involved in biotin biosynthesis. Host cells of the present invention can either be indigenously (i.e., naturally) capable of biotin production or can be capable of producing biotin after being transformed with at least one nucleic acid sequence of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">A preferred host cell of the present invention is a cell in which the indigenous (i.e., intrinsic, natural) production of biotin is deregulated. As used herein, a cell's indigenous production of biotin refers to biotin production by the host cell prior to being transformed by nucleic acid sequences of the present invention. A cell's indigenous production of biotin can be deregulated in a variety of ways including, but not limited to, alleviating the controls a cell normally exerts on the synthesis of enzymes of the biotin biosynthetic pathway (e.g., repression), modifying enzymes of the biotin biosynthetic pathway to have higher specific activities (including reduction of feedback inhibition), and increasing the gene copy number of genes encoding enzymes of the biotin biosynthetic pathway (including by transformation). A cell that is no longer susceptible to repression by high biotin concentrations because, for example, the biotin repressor is no longer functional, is a particularly preferred host for recombinant molecules containing genes operatively linked to their indigenous transcription control sequences (i.e., to sequences that are subject to regulation by biotin).</div>
    <div class="description-paragraph style-scope patent-text">Cells in which the synthesis and/or activity of particular enzymes of the biotin biosynthetic pathway are deregulated are particularly useful as host cells into which to introduce particular nucleic acid sequences. For example, a <i class="style-scope patent-text">Bacillus sphaericus </i>cell in which the enzymes encoded by the gene clusters bioXWF and bioDAYB are deregulated would be a preferred host to be transformed by a recombinant molecule containing an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or functional equivalent thereof.</div>
    <div class="description-paragraph style-scope patent-text">Preferred host cells of the present invention include, but are not limited to, bacteria and yeast. More preferred host cells include those of the genera Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, and Saccharomyces. Preferred species of host cells include <i class="style-scope patent-text">Escherichia coli, Bacillus sphaericus, </i>and <i class="style-scope patent-text">Bacillus subtilis, </i>with <i class="style-scope patent-text">Escherichia coli </i>being more preferred.</div>
    <div class="description-paragraph style-scope patent-text">A recombinant cell of the present invention is a host cell that is transformed with at least one nucleic acid of the present invention. Recombinant cells transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or functional equivalent thereof, alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, or bioY genes, or a functional equivalent of any of these genes, are capable of producing at least about 25 percent of their total biotin production as true biotin. Recombinant cells transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene or functional equivalent thereof alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, or a functional equivalent of any of these genes, are capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof.</div>
    <div class="description-paragraph style-scope patent-text">Preferably, a recombinant cell is produced by transforming a host cell with one or more recombinant molecules containing one or more nucleic acid sequences of the present invention. As such, host cells can be transformed with single recombinant molecules containing any desired nucleic acid sequences to improve biotin production. Alternatively, host cells can be transformed with multiple recombinant molecules, each containing a subset of the desired combination of nucleic acid sequences such that in total, all desired nucleic acid sequences are transformed into the host cell.</div>
    <div class="description-paragraph style-scope patent-text">Transformation can be accomplished using any process by which nucleic acid sequences are inserted into a cell. Transformation techniques include, but are not limited to, transfection, electroporation, microinjection, lipofection, adsorption, and protoplast fusion. A recombinant cell may remain unicellular or may grow into a tissue or a multicellular organism. Transformed nucleic acid sequences of the present invention can remain extrachromosomal or can integrate into one or more sites within a chromosome of a host cell in such a manner that their ability to be expressed is retained. Integrated nucleic acid sequences often are more stable than extrachromosomal sequences. As such, it is within the scope of the present invention that expression of nucleic acid sequences encoding enzymes involved in biotin biosynthesis may be due to expression of plasmid sequences or to sequences integrated into the host genome.</div>
    <div class="description-paragraph style-scope patent-text">Preferred recombinant cells of the present invention include cells transformed with nucleic acid sequence combinations E, EB, EBD, EBDA, EBDAF, EBDAFWXY, H, BH, EH, BEH, BEDH, BEDAH, BEDAFH, and BEDAFCH. Preferably such nucleic acid sequence combinations are operatively linked to at least one transcription control sequence, and preferably to at least one bacteriophage T7, tac and/or lac transcription control sequence. Particularly preferred recombinant cells include cells transformed with one or more nucleic acid sequence combinations described in Table 1. Such sequences are preferably operatively linked to a yeast or bacterial transcription control sequence, and more preferably to at least one bacteriophage T7, tac and/or lac transcription control sequence when expressed in <i class="style-scope patent-text">Escherichia coli </i>cells, and to a bacteriophage SP01 transcription control sequence when expressed in Bacillus cells. Preferred recombinant cells are transformed with combinations of recombinant molecules that contain the nucleic acid sequences E<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, H<sup class="style-scope patent-text">col</sup>, or E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col </sup>operatively linked to a bacteriophage T7, tac, or lac transcription control sequence, and preferably to a T7 transcription control sequence. Preferred recombinant molecules contain the nucleic acid sequences E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, or E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col </sup>operatively linked to at least one transcription control sequence. In all cases, the order of the genes is illustrative and can be any permutation thereof. Particularly preferred recombinant molecules include pDIPE<sup class="style-scope patent-text">col</sup>, pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, pCKRH<sup class="style-scope patent-text">col</sup>, pCKRH′<sup class="style-scope patent-text">col</sup>, pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. Recombinant cells that are particularly preferred include <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup> <i class="style-scope patent-text">, Escherichia coli </i>BL21/DE3-pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup> <i class="style-scope patent-text">, Escherichia coli </i>BL21/DE3-pCKRH<sup class="style-scope patent-text">col</sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup> <i class="style-scope patent-text">, Escherichia coli </i>BL21/DE3-pCKRH′<sup class="style-scope patent-text">col</sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup> <i class="style-scope patent-text">, Escherichia coli </i>BL21/DE3-pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3-pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Another embodiment of the present invention is a recombinant cell that is produced by transforming a host other than <i class="style-scope patent-text">Escherichia coli </i>with a recombinant molecule comprising an <i class="style-scope patent-text">Escherichia coli </i>bioE gene. Such a recombinant cell can also include one or more additional genes involved in biotin biosynthesis such as <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioF, and bioH genes, and/or <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioW, bioX, and bioY genes, or functional equivalents of any of those genes. Preferred recombinant cells are bacterial and yeast cells. More preferred recombinant cells are of the genus Bacillus, preferably of the species <i class="style-scope patent-text">Bacillus sphaericus. </i> </div>
    <div class="description-paragraph style-scope patent-text">It may be appreciated by one skilled in the art that use of recombinant DNA technologies can improve expression of transformed nucleic acid sequences by manipulating, for example, the number of copies of the nucleic acid sequences within a host cell, the efficiency with which those nucleic acid sequences are transcribed, the efficiency with which the resultant transcripts are translated, and the efficiency of post-translational modifications. Recombinant techniques useful for increasing the expression of nucleic acid sequences encoding enzymes involved in biotin synthesis include, but are not limited to, operatively linking nucleic acid sequences to high-copy number plasmids, integration of the nucleic acid sequences into one or more host cell chromosomes, addition of vector stability sequences to plasmids, substitutions or modifications of transcription control signals (e.g., promoters, operators, enhancers), substitutions or modifications of translational control signals (e.g., ribosome binding sites, shine-Delgarno sequences), modification of the nucleic acid sequences encoding enzymes involved in biotin biosynthesis to correspond to the codon usage of the host cell, deletion of sequences that destabilize transcripts, and use of control signals that temporally separate recombinant cell growth from recombinant enzyme production during fermentation. The activity of an expressed recombinant enzyme of the present invention may be improved by fragmenting, modifying, or derivatizing nucleic acid sequences encoding enzymes involved in biotin biosynthesis.</div>
    <div class="description-paragraph style-scope patent-text">According to the present invention, a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, either alone or in combination with at least one additional nucleic acid sequence selected from the group consisting of <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, bioD, bioF, bioX, bioW, and bioY genes, or functional equivalents of any of these genes, is particularly useful in that such a cell is capable of efficiently converting biotin vitamers to true biotin when cultured in an effective medium, such that at least about 25 percent of the biotin produced by the cell is true biotin. The present invention includes all recombinant cells produced as described above that are capable of producing a percentage amount of true biotin in excess of that produced by cells transformed with <i class="style-scope patent-text">Bacillus sphaericus </i>biotin gene clusters that have been described in the literature. In preferred recombinant cells, at least about 50 percent, more preferably at least about 75 percent, and even more preferably at least about 90 percent of the biotin produced is true biotin. It is within the scope of the present invention that a recombinant cell of the present invention can produce essentially about 100 percent true biotin (i.e., that substantially all of the total biotin produced is true biotin).</div>
    <div class="description-paragraph style-scope patent-text">It should be noted that the ability of recombinant cells of the present invention to efficiently convert biotin vitamers to true biotin does not depend on the total amount of biotin produced. That is, regardless of the amount of biotin a recombinant cell can inherently produce, the present invention teaches a method of biotin production such that at least about 25 percent, preferably at least about 50 percent, more preferably at least about 75 percent, even more preferably at least about 90%, and even more preferably essentially about 100 percent of the biotin produced by the cell comprises true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Another embodiment of the present invention is the use of a cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene or functional equivalent thereof alone or in combination with at least one nucleic acid sequence selected from <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes, or a functional equivalent of any of these genes, to produce biotin. When cultured in an effective medium, such recombinant cells are capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof. As used herein, “more biotin” is any measurable difference of biotin production between the two strains. Preferably, recombinant cells transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof, produce at least about 50 percent more, more preferably at least about 2 times more, and even more preferably at least about 4 times more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, or functional equivalent thereof.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, an “effective medium” refers to any medium in which a recombinant cell, when cultured, is capable of producing biotin in desired amounts. An effective medium is typically an aqueous medium comprising assimilable carbohydrate, nitrogen and phosphate sources, as well as appropriate salts, minerals, metals and other nutrients, such as vitamins. The medium may comprise complex nutrients or may be a defined minimal medium. Recombinant cells of the present invention can be cultured in conventional fermentation bioreactors, which include, but are not limited to, batch, fed-batch, cell recycle, and continuous fermentors. Culturing is carried out at a temperature, pH and oxygen content appropriate for the recombinant cell. Such culturing conditions are well within the expertise of one of ordinary skill in the art.</div>
    <div class="description-paragraph style-scope patent-text">In a preferred embodiment, the effective medium is supplemented with an effective amount of a compound that promotes biotin production. Such compounds include biotin precursors or derivatives thereof that, when fed to the cells, enable the cells to produce increased amounts of biotin. An effective amount of such a compound is an amount such that the particular step of the biotin synthetic pathway being supplemented is no longer rate limiting. Biotin precursors that can be added to the media include, but are not limited to, at least one dicarboxylic acid or derivative thereof, at least one biotin vitamer or derivative thereof, and mixtures thereof. Preferred dicarboxylic acids include pimelic acid, azelaic acid, and derivatives of either, with pimelic acids and derivatives thereof being more preferred. As used herein, “derivatives thereof” are compounds with similar functional characteristics to the compounds. For example, pimelyl-CoA is considered to be a derivative of pimelic acid. Pelargonic acids and their derivatives are preferred biotin vitamer supplements. Preferred pelargonic acid supplements include 7-keto-8-aminopelargonic acid, 7,8-diaminopelargonic acid, and derivatives of either.</div>
    <div class="description-paragraph style-scope patent-text">According to one aspect of the present invention, recombinant cells are cultured in an effective medium supplemented by a biotin precursor to increase the amount of biotin produced by a cell. Preferably, the nature of the biotin precursor used is dependent upon the genetic make-up of the recombinant cell. In a preferred embodiment, a desirable biotin precursor supplement is a compound that is produced by a reaction in the biotin biosynthetic pathway that is essentially immediately upstream of (i.e., just prior to) the reactions carried out by enzymes encoded by the genes transformed into the recombinant cell being cultured. For example, a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene or a functional equivalent thereof, and with <i class="style-scope patent-text">Bacillus sphaericus </i>bioB, bioD, bioA, bioF, and bioW (with or without bioX and bioY) genes, or functional equivalents thereof, (e.g., a recombinant cell transformed with the nucleic acid sequence combination E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup>or E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>W<sup class="style-scope patent-text">sph</sup>X<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>) is cultured in an effective medium supplemented with a dicarboxylic acid, such as pimelic acid or azelaic acid, or a derivative thereof. One or more biotin vitamers can also be added to the medium. However, for such recombinant cells, a preferred supplement is pimelic acid or a derivative thereof since the enzymes encoded by the genes transformed into the cells should be capable of converting essentially all of the pimelic acid to true biotin rather than to biotin vitamers.</div>
    <div class="description-paragraph style-scope patent-text">In an analogous fashion, the effective medium of a recombinant cell transformed with the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, and with <i class="style-scope patent-text">Bacillus sphaericus </i>bioA, bioB, and bioD genes, or functional equivalents thereof, is preferably supplemented with 7-keto-8-aminopelargonic acid. Similarly, the effective medium of a recombinant cell transformed with the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, or a functional equivalent thereof, and with <i class="style-scope patent-text">Bacillus sphaericus </i>bioB and bioD genes, or functional equivalents thereof, is peferably supplemented with 7,8-diaminopelargonic acid.</div>
    <div class="description-paragraph style-scope patent-text">In a preferred embodiment of the present invention using a recombinant cell transformed by an <i class="style-scope patent-text">Escherichia coli </i>bioE gene to enhance conversion of biotin vitamers to true biotin, biotin is produced by a method including: (a) operatively linking a first nucleic acid sequence containing <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes to a transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a first recombinant molecule denoted pAEBFCD in which expression of all six genes is under the control of the transcription control sequence; (b) ligating a second nucleic acid sequence containing <i class="style-scope patent-text">Bacillus sphaericus </i>bioX, bioW, and bioY genes into the first recombinant molecule between the <i class="style-scope patent-text">Escherichia coli </i>bioE and <i class="style-scope patent-text">Escherichia coli </i>bioB genes to form a second recombinant molecule denoted pAEXWYBFCD in which expression of all nine genes is under the control of the transcription control sequence; (c) transforming the second recombinant molecule into an <i class="style-scope patent-text">Escherichia coli </i>host cell to form a recombinant cell; (d) culturing the recombinant cell in an effective medium supplemented with pimelic acid or a derivative thereof in order to produce biotin such that at least about 25 percent of the biotin produced is true biotin; and (e) recovering biotin therefrom. Preferably at least about 50 percent, more preferably at least about 75 percent, and even more preferably at least about 90 percent of the total biotin produced is true biotin. Preferred transcription control sequences include those of bacteriophage T7 and/or tac.</div>
    <div class="description-paragraph style-scope patent-text">In another preferred embodiment of the present invention using a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioE gene, biotin is produced by a method including: (a) ligating a first nucleic acid sequence containing the <i class="style-scope patent-text">Escherichia coli </i>bioE gene to a second nucleic acid sequence containing the <i class="style-scope patent-text">Bacillus sphaericus </i>gene cluster bioDAYB to form a third nucleic acid sequence; (b) operatively linking the third nucleic acid sequence to a first transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a first recombinant molecule denoted pbioEDAYB in which expression of all five genes is under the control of the first transcription control sequence; (c) operatively linking a fourth nucleic acid sequence containing the <i class="style-scope patent-text">Bacillus sphaericus </i>gene cluster bioXWF to a second <i class="style-scope patent-text">Escherichia coli </i>transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a second recombinant molecule denoted pbioXWF in which expression of the three genes is under the control of the second transcription control sequence; (d) forming a third recombinant molecule by combining pbioEDAYB and pbioXWF in such a way that expression of <i class="style-scope patent-text">Escherichia coli </i>bioE and the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB gene cluster is under the control of the first transcription control sequence and expression of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF gene cluster is under the control of the second transcription control sequence; (e) transforming the third recombinant molecule into an <i class="style-scope patent-text">Escherichia coli </i>host cell to form a recombinant cell; (f) culturing the recombinant cell in an effective medium supplemented with pimelic acid or a derivative thereof in order to produce biotin such that at least about 25 percent of the biotin produced is true biotin; and (g) recovering biotin therefrom. Preferably at least about 50 percent, more preferably at least about 75 percent, and even more preferably at least about 90 percent of the total biotin produced is true biotin. Preferred transcription control sequences include those of bacteriophage T7 and/or tac. Note that the first and second transcription control sequences can comprise identical transcription control sequences; for example, both transcription control sequences can be bacteriophage T7 transcription control sequences. In an alternative embodiment of this biotin production process, the second nucleic acid sequence contains the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF gene cluster and the third nucleic acid sequence contains the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB gene cluster, thereby leading to co-expression of <i class="style-scope patent-text">Escherichia coli </i>bioE and the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF gene cluster under the control of the first transcription control sequence and expression of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB gene cluster under the control of the second transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">In a preferred embodiment of the present invention using a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene to enhance biotin production, biotin is produced by a method including: (a) operatively linking a first nucleic acid sequence containing <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes to a transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a first recombinant molecule denoted pAEBFCD in which expression of all six genes is under the control of the transcription control sequence; (b) ligating a second nucleic acid sequence containing an <i class="style-scope patent-text">Escherichia coli </i>bioH gene to the first recombinant molecule between the transcription control sequence and the <i class="style-scope patent-text">Escherichia coli </i>bioA gene to form a second recombinant molecule denoted pHAEBFCD in which expression of all seven genes is under the control of the transcription control sequence; (c) transforming an <i class="style-scope patent-text">Escherichia coli </i>cell with the second recombinant molecule to obtain a recombinant cell; (d) culturing the recombinant cell in an effective medium to produce biotin such that the recombinant cell produces more biotin than does a recombinant cell not transformed with the <i class="style-scope patent-text">Escherichia coli </i>bioH gene; and (e) recovering biotin therefrom. Preferred transcription control sequences include those of bacteriophage T7.</div>
    <div class="description-paragraph style-scope patent-text">In another preferred embodiment of the present invention using a recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, biotin is produced by a method including (a) operatively linking a first nucleic acid sequence containing an <i class="style-scope patent-text">Escherichia coli </i>bioH gene to a first transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a first recombinant molecule denoted pH; (b) operatively linking a second nucleic acid sequence containing <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes to a second transcription control sequence functional in <i class="style-scope patent-text">Escherichia coli </i>to form a second recombinant molecule denoted pAEBFCD in which expression of all six genes is under the control of the transcription control sequence; (c) co-transforming an <i class="style-scope patent-text">Escherichia coli </i>cell with the first and second recombinant molecules to obtain a recombinant cell; (d) culturing the recombinant cell in an effective medium to produce biotin such that the recombinant cell produces more biotin than does a recombinant cell not transformed with the first recombinant molecule; and (e) recovering biotin therefrom. Preferred transcription control sequences include those of bacteriophage T7 and/or tac. Note that the first and second transcription control sequences can be identical as long as together they do not direct a level of expression that would deleteriously affect the cell.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, the term “recovering biotin” simply refers to collecting the whole fermentation medium comprising biotin and need not imply additional steps of separation or purification. Biotin can be further separated and/or purified from the fermentation medium using a variety of techniques known in the art. A simplified biotin purification method which results in high yields of essentially pure biotin is described in co-pending U.S. patent application Ser. No. 07/822,449, by Cheung, filed Jan. 17, 1992. Briefly, following fermentation, cells are separated from the biotin-containing supernatant by centrifugation of filtration. The supernatant is passed over an ion-exchange column from which the biotin is eluted using formic acid. This step effectively separates true biotin from biotin vitamers. Eluted fractions containing true biotin are acidified in order to precipitate the biotin, preferably by adjusting the pH of the eluent to a pH of from about <figure-callout id="1" label="pH" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 1 to about <figure-callout id="4" label="pH" filenames="US6277609-drawings-page-10.png,US6277609-drawings-page-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 4. The precipitated true biotin is subsequently dissolved and submitted to at least one step of crystallization.</div>
    <div class="description-paragraph style-scope patent-text">The following examples are provided for the purposes of illustration and are not intended to limit the scope of the invention.</div>
    <heading class="style-scope patent-text">EXAMPLES</heading>
    <div class="description-paragraph style-scope patent-text">In the following examples, all recombinant molecules were analyzed by restriction digests to confirm that the correct nucleic acid sequences were inserted in the proper orientation for transcription.</div>
    <heading class="style-scope patent-text">Example 1</heading>
    <div class="description-paragraph style-scope patent-text">Production of nucleic acid sequences and recombinant molecules containing coding regions of genes involved in the <i class="style-scope patent-text">Escherichia coli </i>biotin biosynthetic pathway</div>
    <div class="description-paragraph style-scope patent-text">A. pCB107</div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a plasmid containing the <i class="style-scope patent-text">Escherichia coli </i>biotin operon including the bioE, bioA, bioB, bioF, bioC, and bioD genes.</div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 2<i class="style-scope patent-text">b, </i>lambda bio-transducing phage bioT124 (Guha et al., pp.53-62, 1971, <i class="style-scope patent-text">J. Mol. Bol., </i>Vol. 56) was digested with restriction enzymes EcoRI and HindIII to produce a 6 kilobase (kb) fragment, denoted EABFCD, which contains the <i class="style-scope patent-text">Escherichia coli </i>bioE, bioA, bioB, bioF, bioC, and bioD genes. Using standard protocols (see Sambrook et al., ibid.), DNA fragment EABFCD was ligated into the pUC18 plasmid (available from GIBCO BRL, Gaithersburg, Md., and shown in FIG. 2<i class="style-scope patent-text">a</i>) that had been digested with EcoRI and HindIII. The resulting plasmid, depicted in FIG. 2<i class="style-scope patent-text">c, </i>is referred to as PCB101.</div>
    <div class="description-paragraph style-scope patent-text">To convert the AccI site in the operator region of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon to a SalI site, pCB101 was digested with AccI, followed by Mung Bean Nuclease. SalI linkers were ligated to the digested plasmid, and the plasmid self-ligated, using standard techniques. The resulting plasmid, denoted pCB107 and shown in FIG. 2<i class="style-scope patent-text">d, </i>contains the <i class="style-scope patent-text">Escherichia coli </i>bioE, bioA, bioB, bioF, bioC, and bioD genes with a SalI site located between the bioA and bioB coding regions. The restriction site conversion resulted in the insertion of 8 base pairs (bp) into the operator site of the biotin operon.</div>
    <div class="description-paragraph style-scope patent-text">B. pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Escherichia coli </i>bioB, bioF, bioC, and bioD genes, operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 3, a 3.8 kb DNA fragment containing the coding regions, but lacking the indigenous (i.e., biotin) transcription control sequences, of the <i class="style-scope patent-text">Escherichia coli </i>bioB, bioF, bioC, and bioD genes and denoted B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, was produced by digesting pCB107 (produced as described in Example 1A and shown in FIG. 2<i class="style-scope patent-text">d</i>) with HindIII and SalI. The DNA fragment was ligated into the expression vector pDIP18 (obtained from Dr. L. Gold, University of Colorado, Boulder, Colo. and shown in FIG. 3<i class="style-scope patent-text">a</i>), that had been restricted with HindIII and SalI, in such a manner as to operatively link B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>to the bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">The resulting recombinant molecule, pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col </sup>D<sup class="style-scope patent-text">col</sup>, also referred to as pDIPBFCD, is shown in FIG. 3<i class="style-scope patent-text">b. </i> </div>
    <div class="description-paragraph style-scope patent-text">C. pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">A 1.8 kb fragment containing the coding regions, but lacking the indigenous transcription control sequences, of the <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes and denoted A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>or bioAbioE, was produced by polymerase chain reaction (PCR) amplification of a portion of W3110 <i class="style-scope patent-text">Escherichia coli </i>genomic DNA (<i class="style-scope patent-text">Escherichia coli </i>W3110 is available from the <i class="style-scope patent-text">Escherichia coli </i>Genetic Stock Center, New Haven, Conn.) using <figure-callout id="1" label="primers #" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>1 and #2 (SEQ ID NO:1 and SEQ ID NO:2, respectively) (see FIG. 4<i class="style-scope patent-text">a</i>). <figure-callout id="1" label="Primers #" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Primers #</a></figure-callout>1 and #2 (SEQ ID NO:1 and SEQ ID NO:2, respectively) contain the restriction sites EcoRI and XmaI, respectively, and are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00002" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="1" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #1 (SEQ ID NO:1)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ AATCTTTT<u class="style-scope patent-text">GA ATTC</u>GGTTTA <figure-callout id="3" label="GGAGTCGATT ATG AC" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">GGAGTCGATT <u class="style-scope patent-text">ATG</u> AC</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">            EcoRI                   Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                                    Initiation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                                    site</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #2 (SEQ ID NO:2)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GCGCCA<u class="style-scope patent-text">CCCG <figure-callout id="3" label="GGAGAGTGA TTA AC" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">GG</a></figure-callout> </u> <figure-callout id="3" label="GGAGAGTGA TTA AC" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">AGAGTGA <u class="style-scope patent-text">TTA</u> AC</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">          XmaI          Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                        Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #1 (SEQ ID NO:1) is complementary to (i.e., can hybridize with) a nucleic acid sequence immediately upstream from and containing the translation initiation site of the <i class="style-scope patent-text">Escherichia coli </i>bioA gene. The 5′ end of primer #1 (SEQ ID NO:1) is about 5 bp downstream from (i.e., 3′ of) the transcription initiation site of the <i class="style-scope patent-text">Escherichia coli </i>bioA gene. As such, resulting PCR fragment A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>does not include an indigenous transcription control sequences and, therefore, can be operatively linked to a transcription control sequence not normally associated with the <i class="style-scope patent-text">Escherichia coli </i>bioA gene. Primer #2 (SEQ ID NO:2) is complementary to a nucleic acid sequence including and immediately downstream from the stop codon (UAA) of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <div class="description-paragraph style-scope patent-text">Following amplification, PCR fragment A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>was digested with EcoRI and XmaI and ligated to expression vector pDIP18 (see FIG. 4<i class="style-scope patent-text">b</i>) that had been restricted with EcoRI and XmaI. As such, the <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes were operatively linked to the bacteriophage T7 transcription control sequence to form recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, also referred to as pDIPAE (see FIG. 4<i class="style-scope patent-text">c</i>).</div>
    <div class="description-paragraph style-scope patent-text">D. pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the entire biotin operon including the <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes, operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">PCR fragment A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, produced as described in Example 1C and depicted in FIG. 4<i class="style-scope patent-text">a </i>as bioAbioE, was digested with EcoRI and XmaI and ligated, as shown in FIG. 5, to the recombinant molecule pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1B and depicted in FIG. 3<i class="style-scope patent-text">b</i>) that had been restricted with XmaI and EcoRI. As such, the <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes, in addition to the bioB, bioF, bioC, and bioD genes, were operatively linked to the bacteriophage T7 transcription control sequence to form recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, also referred to as pDIPAEBFCD (see FIG. 5<i class="style-scope patent-text">a</i>).</div>
    <div class="description-paragraph style-scope patent-text">E. pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon, except for the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, (i.e., containing <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioF, bioC, and bioD genes) operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">A 1.2 kb fragment containing the coding region, but lacking the indigenous transcription control sequence, of the <i class="style-scope patent-text">Escherichia coli </i>bioA gene and denoted A<sup class="style-scope patent-text">col </sup>or bioA, was produced by PCR amplification of a portion of W3110 <i class="style-scope patent-text">Escherichia coli </i>genomic DNA using <figure-callout id="1" label="primers #" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>1 and #3 SEQ ID NO:1 and SEQ ID NO:3, respectively). See FIG. 6<i class="style-scope patent-text">a. </i>Primer #3 (SEQ ID NO:3) contains the restriction site KpnI and is shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00003" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #3 (SEQ ID NO:3)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GTGTGT<u class="style-scope patent-text">GGTA CC</u> <u class="style-scope patent-text">TTA</u> TTG <figure-callout id="3" label="GCA AAA AAA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">GCA AAA AAA</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">           KpnI  Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                 Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #3 (SEQ ID NO:3) is complementary to a nucleic acid sequence including and immediately downstream from the stop codon (UAA) of the <i class="style-scope patent-text">Escherichia coli </i>bioA gene. Following amplification, PCR fragment A<sup class="style-scope patent-text">col </sup>was digested with EcoRI and KpnI and ligated, as shown in FIG. 6, to the recombinant molecule pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1B and depicted in FIG. 3<i class="style-scope patent-text">b</i>) that had been restricted with EcoRI and KpnI. As such, the <i class="style-scope patent-text">Escherichia coli </i>bioA gene, in addition to the bioB, bioF, bioC, and bioD genes, was operatively linked to the bacteriophage T7 transcription control sequence to form recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, also referred to as pDIPABFCD (see FIG. 6<i class="style-scope patent-text">b</i>).</div>
    <div class="description-paragraph style-scope patent-text">F. pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes production of a recombinant molecule in which the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon (i.e., <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes) are operatively linked to a lac transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">A 6 kb fragment containing the T7 promoter operatively linked to the <i class="style-scope patent-text">Escherichia coli </i>bioA, bioE, bioB, bioF, bioC, and bioD genes was produced by PCR amplification from purified pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>DNA (produced as described in Example 1D and depicted in FIG. 5<i class="style-scope patent-text">a </i>as pDIPAEBFCD), using <figure-callout id="4" label="primers #" filenames="US6277609-drawings-page-10.png,US6277609-drawings-page-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>4 and #5 (SEQ ID NO:4 and SEQ ID NO:5, respectively). See FIG. 7<i class="style-scope patent-text">a. </i>The primer sequences are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00004" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #4 (SEQ ID NO:4)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′<figure-callout id="3" label="TAATACGACT CACTATAGGG AGA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TAATACGACT CACTATAGGG AGA</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #5 (SEQ ID NO:5)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′CATGAT<u class="style-scope patent-text">GAAT TC</u>AAGGCAAG GT <u class="style-scope patent-text">TTA</u> TGT AC</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">          EcoRI             Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                            Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #4 (SEQ ID NO:4) is complementary to the nucleic acid sequence of the T7 promoter which is about 22 <figure-callout id="5" label="bp" filenames="US6277609-drawings-page-10.png,US6277609-drawings-page-9.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">bp</a></figure-callout> 5′ of the EcoRI site of pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. Primer #5 (SEQ ID NO:5) is complementary to the nucleic acid sequence including and immediately downstream of the stop codon (UAA) of the <i class="style-scope patent-text">Escherichia coli </i>bioD gene.</div>
    <div class="description-paragraph style-scope patent-text">Following PCR amplification, the 6 kb PCR fragment was digested with EcoRI and ligated to pUC18 (see FIG. 7<i class="style-scope patent-text">b</i>) that had been restricted with EcoRI. This results in removal of the T7 promoter sequences as indicated in FIG. <b class="style-scope patent-text">7</b>. This recombinant molecule is pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, also referred to as pUCAEBFCD (see FIG. 7<i class="style-scope patent-text">c</i>).</div>
    <div class="description-paragraph style-scope patent-text">G. pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes production of a recombinant molecule containing the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon except for the <i class="style-scope patent-text">Escherichia coli </i>bioE gene (i.e., containing <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioF, bioC, and bioD genes) operatively linked to a lac transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">A 5 kb fragment containing the T7 promoter operatively linked to the <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioF, bioC, and bioD genes was produced by PCR amplification from purified pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>DNA (produced as described in Example 1E and depicted in FIG. 6<i class="style-scope patent-text">b</i>), using <figure-callout id="4" label="primers #" filenames="US6277609-drawings-page-10.png,US6277609-drawings-page-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>4 and #5 (SEQ ID NO:4 and SEQ ID NO:5, respectively) of Example 1F. See FIG. 8<i class="style-scope patent-text">a. </i> </div>
    <div class="description-paragraph style-scope patent-text">Following PCR amplification, the 5 kb PCR fragment was digested with EcoRI and ligated to pUC18 (see FIG. 8<i class="style-scope patent-text">b</i>) that had been restricted with EcoRI. This results in removal of the T7 promoter sequences as indicated in FIG. <b class="style-scope patent-text">8</b>. This recombinant molecule is pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, also referred to as pUCABFCD (see FIG. 8<i class="style-scope patent-text">c</i>).</div>
    <div class="description-paragraph style-scope patent-text">H. E<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a nucleic acid fragment containing the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <div class="description-paragraph style-scope patent-text">An approximately 600 bp fragment, called E<sup class="style-scope patent-text">col </sup>or bioE, containing the bioE coding sequence was isolated by PCR amplification of pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(described in Example 1D and depicted in FIG. 5<i class="style-scope patent-text">a</i>) using <figure-callout id="6" label="primers #" filenames="US6277609-drawings-page-11.png,US6277609-drawings-page-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>6 and #2 (SEQ ID NO:2 and SEQ ID NO:6, respectively). See FIG. 9<i class="style-scope patent-text">a. </i>The sequence of primer #6 (SEQ ID NO:6) is shown below. Primer #2 (SEQ ID NO:2) was described in Example 1C.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00005" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #6 (SEQ ID NO:6)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">ATAT<u class="style-scope patent-text">GGGCCC</u> AAACAAGAAA GGAGGGTTC <u class="style-scope patent-text">ATG</u> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">     XmaI                       Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                                Start site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #6 (SEQ ID NO:6) is complementary to a nucleic acid sequence immediately upstream from and containing the translation initiation site of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene. Primer #2 (SEQ ID NO:2) is complementary to a nucleic acid sequence including and immediately downstream from the stop codon (UAA) of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <heading class="style-scope patent-text">Example 2</heading>
    <div class="description-paragraph style-scope patent-text">Production of nucleic acid sequences containing coding regions of genes involved in the <i class="style-scope patent-text">Bacillus sphaericus </i>biotin biosynthetic pathway</div>
    <div class="description-paragraph style-scope patent-text">A. X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a nucleic acid sequence containing <i class="style-scope patent-text">Bacillus sphaericus </i>bioX, bioW, and bioY genes.</div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 10, two DNA fragments containing the coding regions of <i class="style-scope patent-text">Bacillus sphaericus </i>bioX and bioW genes and of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioY gene, respectively, were amplified from <i class="style-scope patent-text">Bacillus sphaericus </i>strain ATCC No. 10208 using PCR amplification. Ligation of the two original fragments resulted in a DNA fragment containing a bioXWY gene cluster. Details of the production of such nucleic acid sequences follow.</div>
    <div class="description-paragraph style-scope patent-text">A 1.1 kb PCR fragment called X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph </sup>or bioXbioW, which includes the coding regions of <i class="style-scope patent-text">Bacillus sphaericus </i>bioX and bioW genes but lacks indigenous transcription control sequences, was synthesized using <figure-callout id="7" label="primers #" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>7 and #8 (SEQ ID NO:7 and SEQ ID NO:8, respectively). See FIG. 10<i class="style-scope patent-text">a. </i>The primers contain the restriction sites XmaI and NotI, respectively, and are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00006" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #7 (SEQ ID NO:7)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ <figure-callout id="3" label="ATATATCCCG GGTTAACTCA AATTG" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ATATAT<u class="style-scope patent-text">CCCG GG</u>TTAACTCA AATTG</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">          XmaI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #8 (SEQ ID NO:8)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ CCC<u class="style-scope patent-text">GCGGCCG C</u>TCAT <u class="style-scope patent-text">TCA</u> TTT TAA <figure-callout id="3" label="ATC CCC C" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ATC CCC C</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">       NotI         Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                    Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #7 (SEQ ID NO:7) is complementary to a nucleic acid sequence, the 3′ end of which is about 28 bp upstream from the translation start site of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioX gene. Primer #8 (SEQ ID NO:8) is complementary to a nucleic acid sequence including and immediately downstream from stop codon (UGA) of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioW gene.</div>
    <div class="description-paragraph style-scope patent-text">A 0.6 kb PCR fragment called Y<sup class="style-scope patent-text">sph</sup>, or bioY, which includes the coding regions of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioY gene but lacks indigenous transcription control sequences, was synthesized using <figure-callout id="9" label="primers #" filenames="US6277609-drawings-page-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>9 and #10 (SEQ ID NO:9 and SEQ ID NO:10, respectively). See FIG. 10<i class="style-scope patent-text">b. </i>The primers contain the restriction sites NotI and XmaI, respectively, and are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00007" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #9 (SEQ ID NO:9)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′TGAATGA<u class="style-scope patent-text">GCG <figure-callout id="3" label="GCCGCGGGAG GGATGAGGGC A" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">GCCGC</a></figure-callout> </u> <figure-callout id="3" label="GCCGCGGGAG GGATGAGGGC A" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">GGGAG GGATGAGGGC <u class="style-scope patent-text">A</u> </a></figure-callout> <u class="style-scope patent-text"> </u>  3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">           NotI                    Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                                   Initiation site</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #10 (SEQ ID NO:10)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′CTATAT<u class="style-scope patent-text">CCCG GG</u>AAT <u class="style-scope patent-text">TCA</u> <figure-callout id="3" label="CTA AAC ATT" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">CTA AAC ATT</a></figure-callout>  3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">          XmaI     Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                   Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #9 (SEQ ID NO:9) is complementary to a nucleic acid sequence immediately upstream from and containing the translation initiation site of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioY gene. Primer #10 (SEQ ID NO:10) is complementary to a nucleic acid sequence including and immediately downstream from the stop codon (UGA) of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioY gene.</div>
    <div class="description-paragraph style-scope patent-text">Following PCR amplification, PCR fragments X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph </sup>and Y<sup class="style-scope patent-text">sph </sup>were digested with NotI and ligated to each other and amplified by PCR to form a 1.7 kb PCR fragment referred to as X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>, also referred to as bioXbioWbioY (see FIG. 10<i class="style-scope patent-text">c</i>).</div>
    <div class="description-paragraph style-scope patent-text">B. X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">A 2.4 kb PCR fragment, called X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>, of bioXbioWbioF, which includes the coding regions of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF gene cluster is synthesized using <figure-callout id="7" label="primers #" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>7 and #11 (SEQ ID NO:7 and SEQ ID NO:11, respectively). See FIG. 11<i class="style-scope patent-text">a. </i>The primers contain the restriction sites XmaI and HindIII, respectively. Primer #7 (SEQ ID NO:7) has been described previously in Example 2A. Primer #11 (SEQ ID NO:11) is shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00008" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #11 (SEQ ID NO:11)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GATAT<u class="style-scope patent-text">AAG CTT</u>CAAACAA <u class="style-scope patent-text">TTA</u> <figure-callout id="3" label="TAC AAT CC" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TAC AAT CC</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">        HindIII        Translational</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">                       Stop site</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #7 (SEQ ID NO:7) is complementary to a nucleic acid sequence the 3′ end of which is about 28 bp upstream from the translation start site of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioX gene. Primer #11 (SEQ ID NO:11) is complementary to a nucleic acid sequence which includes the translational stop site of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioF gene.</div>
    <div class="description-paragraph style-scope patent-text">C. D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">A 3.7 kb PCR fragment, called D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>or bioDbioAbioYbioB, which includes the coding regions of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB gene cluster is synthesized using <figure-callout id="12" label="primers #" filenames="US6277609-drawings-page-13.png,US6277609-drawings-page-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primers #</a></figure-callout>12 and #13 (SEQ ID NO:12 and SEQ ID NO:13, respectively). See FIG. 11<i class="style-scope patent-text">b. </i>The primers each contain the restriction site HindIII, and are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00009" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="1" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #12 (SEQ ID NO:12)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ TTTCCC<u class="style-scope patent-text">AAGC <figure-callout id="3" label="TTTGCACACT TCTGTTTCGT ATCCTCA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TT</a></figure-callout> </u> <figure-callout id="3" label="TTTGCACACT TCTGTTTCGT ATCCTCA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TGCACACT TCTGTTTCGT ATCCTCA</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">         HindIII</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #13 (SEQ ID NO:13)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ CCTGGG<u class="style-scope patent-text">AAGC <figure-callout id="3" label="TTTCATTGAA CATTTTGTGA AAACCATCA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TT</a></figure-callout> </u> <figure-callout id="3" label="TTTCATTGAA CATTTTGTGA AAACCATCA" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TCATTGAA CATTTTGTGA AAACCATCA</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">         HindIII</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">The 3′ end of Primer #12 (SEQ ID NO:12) is complementary to a nucleic acid sequence about 456 <figure-callout id="5" label="bp" filenames="US6277609-drawings-page-10.png,US6277609-drawings-page-9.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">bp</a></figure-callout> 5′ of the translational start of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioD gene. The 3′ end of Primer #13 (SEQ ID NO:13) is complementary to a nucleic acid sequence about 54 <figure-callout id="3" label="bp" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">bp</a></figure-callout> 3′ of the translational stop codon of the <i class="style-scope patent-text">Bacillus sphaericus </i>bioB gene.</div>
    <heading class="style-scope patent-text">Example 3</heading>
    <div class="description-paragraph style-scope patent-text">Production of recombinant molecules containing nucleic acid sequences involved in the <i class="style-scope patent-text">Bacillus sphaericus </i>and <i class="style-scope patent-text">Escherichia coli </i>biotin biosynthetic pathways</div>
    <div class="description-paragraph style-scope patent-text">A. pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Bacillus sphaericus </i>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup>gene cluster and the entire <i class="style-scope patent-text">Escherichia coli </i>biotin operon, except for the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 12, PCR fragment X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup>(produced as described in Example 2A and depicted in FIG. 10<i class="style-scope patent-text">c </i>as bioXbioWbioY) was digested with XmaI and ligated into recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(prepared as described in Example 1E and depicted in FIG. 6<i class="style-scope patent-text">b</i>) that had been digested with XmaI. The resulting recombinant molecule is referred to as pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, or pDIPAXWYBFCD (see FIG. 12<i class="style-scope patent-text">a</i>).</div>
    <div class="description-paragraph style-scope patent-text">B. pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the entire biotin operon, including the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, and the <i class="style-scope patent-text">Bacillus sphaericus </i>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup>gene cluster operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 13, PCR fragment X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph </sup>(produced as described in Example 2A and depicted in FIG. 10<i class="style-scope patent-text">c </i>as bioXbioWbioY) was digested with XmaI and ligated to recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col </sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1D and shown in FIG. 5<i class="style-scope patent-text">a</i>) that had been digested with XmaI. The resulting recombinant molecule is referred to as pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, or pDIPAEXWYBFCD (see FIG. 13<i class="style-scope patent-text">a</i>).</div>
    <div class="description-paragraph style-scope patent-text">C. pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Bacillus sphaericus </i>gene cluster bioXWF operatively linked to a T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">Following PCR amplification, the PCR fragment X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup>(produced as described in Example 2B and depicted in FIG. 11<i class="style-scope patent-text">a </i>as bioXbioWbioF) is digested with XmaI and HindIII and ligated, as shown in FIG. 14, to the expression vector pDIP18 (see FIG. 14<i class="style-scope patent-text">a</i>) that is digested with XmaI and HindIII. As such, the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWF genes are operatively linked to a T7 transcription control sequence to form the recombinant molecule pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>, denoted pDIPXWF in FIG. 14<i class="style-scope patent-text">b. </i> </div>
    <div class="description-paragraph style-scope patent-text">D. pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Bacillus sphaericus </i>gene clusters bioXWF and bioDAYB, operatively linked to a T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">The 3.7 kb fragment containing <i class="style-scope patent-text">Bacillus sphaericus </i>gene cluster bioDAYB (produced as described in Example 2C and depicted in FIG. 11<i class="style-scope patent-text">b </i>as bioDbioAbioYbioB) is digested with HindIII and ligated into pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph </sup>(produced as described in Example 3C and depicted in FIG. 14<i class="style-scope patent-text">b</i>) that is digested with HindIII. The correct orientation produces the recombinant molecule pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, denoted pDIPXWFDAYB as shown in FIG. 14<i class="style-scope patent-text">c. </i> </div>
    <div class="description-paragraph style-scope patent-text">E. pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the <i class="style-scope patent-text">Escherichia coli </i>bioE gene associated with the <i class="style-scope patent-text">Bacillus sphaericus </i>gene cluster bioXWF, and the <i class="style-scope patent-text">Bacillus sphaericus </i>bioDAYB gene cluster. Each gene in the recombinant molecule is operatively linked to a common T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">The E<sup class="style-scope patent-text">col </sup>fragment (described in Example 1H and depicted in FIG. 9<i class="style-scope patent-text">a </i>as bioE), containing the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, is digested with XmaI and ligated into pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>(produced as described in Example 3D and depicted in FIG. 14<i class="style-scope patent-text">c</i>) that is digested with XmaI. The resulting plasmid is called pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, denoted pDIPEXWFDAYB in FIG. 15<i class="style-scope patent-text">a. </i> </div>
    <heading class="style-scope patent-text">Example 4</heading>
    <div class="description-paragraph style-scope patent-text">Production of recombinant cells</div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of recombinant cells transformed with recombinant molecules pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col </sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>.</div>
    <div class="description-paragraph style-scope patent-text">A. Production of recombinant cells using <i class="style-scope patent-text">Escherichia coli </i>SA291 cells</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecules pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, produced as described in Examples 1F and 1G, respectively, as well as the pUC18 vector alone, were transformed into <i class="style-scope patent-text">Escherichia coli </i>SA291 cells (Cleary et al., pp. 2219-2223, 1972, <i class="style-scope patent-text">Proc. Natl. Acad. Sci. </i>69) using techniques similar to those described in Sambrook et al., ibid. Note that in <i class="style-scope patent-text">Escherichia coli </i>SA291 cells, the bacterial chromosome has a deletion spanning chlA to uvrB, which includes the biotin operon; thus SA291 cells lack the entire biotin operon. Transformed cells were identified by their ability to grow on medium containing about 75 μg per ml of ampicillin. A recombinant cell transformed with pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>was denoted SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. A recombinant cell transformed with pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>was denoted SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. A cell transformed with pUC18 was denoted SA291-pUC18.</div>
    <div class="description-paragraph style-scope patent-text">B. Production of recombinant cells using <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecules pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Examples 1C, 1B, 1E, and 1D, respectively), as well as expression vector pDIP18, were each transformed into <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells (Studier et al., pp.113-130, 1986, <i class="style-scope patent-text">J. Mol. Biol., </i>Vol. 189) using techniques similar to those described in Sambrook et al., ibid. <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells have a T7 <figure-callout id="1" label="RNA polymerase gene" filenames="US6277609-drawings-page-12.png,US6277609-drawings-page-6.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">RNA polymerase gene</a></figure-callout> 1 integrated into the genome under the control of lacUV5 promoter and operator sequences. Recombinant cells were selected for their ability to grow in the presence of about 34 μg per ml of chloramphenicol. The resulting recombinant cells were denoted BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE 3-pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, respectively. Cells transformed with pDIP18 were denoted BL21/DE3-pDIP18.</div>
    <heading class="style-scope patent-text">Example 5</heading>
    <div class="description-paragraph style-scope patent-text">Cross-feeding studies</div>
    <div class="description-paragraph style-scope patent-text">This example describes the use of several biotin auxotrophs as well as recombinant cells SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>to determine which reaction in the biotin biosynthetic pathway is conducted by the protein encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <div class="description-paragraph style-scope patent-text"> <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> strain R877 and bioB<sup class="style-scope patent-text">−</sup> strain R875 were streaked onto plates containing biotin-free nutrient agar (4 g glucose, 2 mM [millimolar] MgSO<sub class="style-scope patent-text">4</sub>, 0.1 mM CaCl<sub class="style-scope patent-text">2</sub>, 12.8 g Na<sub class="style-scope patent-text">2</sub>HPO<sub class="style-scope patent-text">4</sub>, 3 g of KH<sub class="style-scope patent-text">2</sub>PO<sub class="style-scope patent-text">4</sub>, 0.5 g Nacl, 1.0 g NH<sub class="style-scope patent-text">4</sub>Cl, 0.1% vitamin free Casamino acids, 0.1% tryptophan, 0.01% thiamine, and 15 g agar per liter of medium). The plates were incubated for six hours at 30° C. Aliquots of <i class="style-scope patent-text">Escherichia coli </i>bioD<sup class="style-scope patent-text">−</sup> strain R877, bioB<sup class="style-scope patent-text">−</sup> strain R875, bioC<sup class="style-scope patent-text">−</sup> strain R876, bioF<sup class="style-scope patent-text">−</sup> strain R874, and bioA<sup class="style-scope patent-text">−</sup> strain R879, (all available from <i class="style-scope patent-text">Escherichia coli </i>Genetic Stock Center, New Haven, Conn.) as well as SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells (produced as described in Example 4A) were cross-streaked onto the plates streaked with either bioD<sup class="style-scope patent-text">−</sup> strain R877 or bioB<sup class="style-scope patent-text">−</sup> strain R875. The cross-streaked plates were grown for forty-eight hours at 30° C.</div>
    <div class="description-paragraph style-scope patent-text">Growth patterns visible on the plates indicated that the bioD<sup class="style-scope patent-text">−</sup> cells were able to cross-feed the bioC<sup class="style-scope patent-text">−</sup>, bioF<sup class="style-scope patent-text">−</sup>, and bioA<sup class="style-scope patent-text">−</sup> cells. The bioD<sup class="style-scope patent-text">−</sup> cells, however, could not cross-feed the bioB<sup class="style-scope patent-text">−</sup> cells or the SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells. The bioB<sup class="style-scope patent-text">−</sup> cells, however, could cross-feed the SA29l-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells as well as the bioD<sup class="style-scope patent-text">−</sup>, bioC<sup class="style-scope patent-text">−</sup>, bioF<sup class="style-scope patent-text">−</sup>, and bioA<sup class="style-scope patent-text">−</sup> cells. Referring to FIG. 1, the results indicate that the bioE gene encodes an enzyme active in the biotin biosynthesis pathway following the activity encoded by the bioD gene and before the activity encoded by the bioB gene. Since the product of the reaction catalyzed by the enzyme encoded by the bioE gene has properties characteristic of desthiobiotin (e.g., stability and ability to bind to avidin) whereas the product of the reaction catalyzed by the enzyme encode by the bioD gene is labile and unable to bind to avidin, it is believed that the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene is desthiobiotin synthetase.</div>
    <heading class="style-scope patent-text">Example 6</heading>
    <div class="description-paragraph style-scope patent-text">Growth studies using recombinant cells SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>or SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">The requirement of the bioE gene for biotin biosynthesis was confirmed by comparing the growth of SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and SA291 -pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells in the presence or absence of biotin.</div>
    <div class="description-paragraph style-scope patent-text">Growth studies were performed by culturing SA291 cells and recombinant cells SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 4A) in M9CAT, a biotin-free nutrient broth containing 4 g glucose, 2 mM MgSO<sub class="style-scope patent-text">4</sub>, 0.1 mM CaCl<sub class="style-scope patent-text">2</sub>, 12.8 g Na<sub class="style-scope patent-text">2</sub>HPO<sub class="style-scope patent-text">4</sub>, 3 g of KH<sub class="style-scope patent-text">2</sub>PO<sub class="style-scope patent-text">4</sub>, 0.5 g NaCl, 1.0 g NH<sub class="style-scope patent-text">4</sub>Cl, 0.1% vitamin free Casamino acids, 0.1% tryptophan, 0.01% thiamine, and 25 mg ampicillin per liter of medium, in the presence or absence of 1.4 nM (nanomolar) biotin or 5 nM desthiobiotin (DTB). The results shown in Table 2 indicate that SA291-pUC18 cells and SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted SA291-ABFCD) cells required biotin for growth whereas SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted SA291-pUCAEBFCD) cells were able to grow in the absence of biotin. SA291-pUCA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and SA291-pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells were each able to grow in minimal medium supplemented with desthiobiotin, which supports identification of the enzyme encoded by the <i class="style-scope patent-text">Escherichia coli </i>bioE gene as being a desthiobiotin synthetase.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00010" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="1" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <thead valign="bottom" class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="1" morerows="0" rowsep="1" valign="top" class="description-td style-scope patent-text" colspan="1">TABLE 2</td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="1" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="1"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Comparison of the ability of SA291 cells and recombinant</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">cells to grow in the presence and absence of biotin</td>
              </tr>
            
          </tbody></table>
          <table cols="5" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Growth Media</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">M9CAT</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">M9CAT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">×</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Strain/plasmid</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">M9CAT</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">biotin</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">DTB</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="5"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">SA291-pUC18</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">−−−<sup class="style-scope patent-text">1</sup> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++<sup class="style-scope patent-text">2</sup> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">−−−</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">SA291-pUCAEBFCD</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">SA291-pUCABFCD</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">−−−</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++</td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">+++</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td style-scope patent-text" colspan="5"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" valign="top" align="left" class="description-td style-scope patent-text" colspan="5"> <sup class="style-scope patent-text">1</sup>“−” indicates lack of growth </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" valign="top" align="left" class="description-td style-scope patent-text" colspan="5"> <sup class="style-scope patent-text">2</sup>“+” indicates growth </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">These results indicate that the <i class="style-scope patent-text">Escherichia coli </i>bioE gene, as well as the other genes encoding enzymes active in biotin biosynthesis contained on the pUCA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>recombinant molecule, are required to rescue the ability of cells lacking the biotin operon to grow in the absence of biotin.</div>
    <heading class="style-scope patent-text">Example 7</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production by BL21/DE3-pDIPA<sup class="style-scope patent-text">col </sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, and BL21/DE3-pDIP18</div>
    <div class="description-paragraph style-scope patent-text">This example describes studies demonstrating the importance of a DNA fragment including the <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes in production of true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cells BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>, and BL21/DE3-pDIP18 (produced as described in Example 4B) were cultured in shake flasks containing LB broth (10 g of bacto-tryptone, 5 g of bacto-yeast, and 10 g NaCl per liter of medium) plus 34 μg/ml chloramphenicol. When the cells reached an OD<sub class="style-scope patent-text">600 </sub>of about 0.7 units in LB broth, IPTG was added to a final concentration of 0.5 mM IPTG to induce expression of T7 RNA polymerase and, hence, expression of genes on the recombinant molecules. Supernatant samples were collected 90 minutes before IPTG induction as well as at 0, 90, and 180 minutes after IPTG induction and measured for true biotin content using a standard microbiological assay (Ogata et al., pp. 889-894, 1965, Agr. Biol. Chem., Vol. 29). The results are shown in FIG. <b class="style-scope patent-text">16</b>. The amount of true biotin produced by the BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells (denoted pDIPAEBFCD in the Figure) was at least about 13-fold higher than that produced by recombinant cells BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>(denoted pDIPAE), or BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPBFCD), or by BL21/DE3-pDIP18 cells (denoted pDIP18). Thus, cells transformed with <i class="style-scope patent-text">Escherichia coli </i>bioA and bioE genes, in addition to <i class="style-scope patent-text">Escherichia coli </i>bioB, bioF, bioC, and bioD genes, are capable of producing significantly increased amounts of true biotin.</div>
    <heading class="style-scope patent-text">Example 8</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production by recombinant cells BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes studies demonstrating the importance of the <i class="style-scope patent-text">Escherichia coli </i>bioE gene in increasing the production of true biotin.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cells BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE 3-pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>(produced as described in Example 4B) were cultured in shake flasks as described in Example 7. Supernatant samples were collected at 0, 0.5, 3, and 7 hours after IPTG induction and measured for true biotin content using the microbiological assay cited in Example 7. The results are shown in FIG. <b class="style-scope patent-text">17</b>. The results indicate that the amount of true biotin produced by the BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells (denoted in the Figure as pDIPAEBFCD) was about 16-fold higher than the amount produced by recombinant cells BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col </sup>(denoted pDIPAE), BL21/DE3-pDIPB<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPBFCD), or BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPABFCD). Thus, expression of the bioE gene in combination with bioA, bioB, bioF, bioC, and bioD genes, significantly increases true biotin production.</div>
    <heading class="style-scope patent-text">Example 9</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production by recombinant cells transformed with recombinant molecules pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, or pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">co</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes studies that compare the production of total biotin, true biotin and biotin vitamers by cells transformed with recombinant molecules containing or lacking the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecules pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, and pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Examples 1E, 1D, 3A, and 3B, respectively) are transformed into <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells using techniques described in Example 4. The resulting recombinant cells are referred to as BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPABFCD), BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPAEBFCD), BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPAXWYBFCD), and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(denoted pDIPAEXWYBFCD). The recombinant cells are cultured in shake flasks as described in Example 7 with pimelic acid added to the media to a final concentration of 0.5 g/L in cultures of BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>. Supernatant samples are collected at 3 hours after IPTG induction and measured for total biotin, true biotin, and biotin vitamer content using the microbiological assays described in Ogata et al., pp. 889-894, 1965, Agr. Biol. Chem., Vol. 29. The results demonstrate that the bioE gene product is required for the efficient production of true biotin from either endogenous (compare pDIPABFCD to pDIPAEBFCD) or exogenous (compare pDIPAXWYBFCD to pDIPAEXWYBFCD) sources of pimelic acid.</div>
    <heading class="style-scope patent-text">Example 10</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production by recombinant cells BL21/DE3-pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and BL21/DE3-pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes studies that compare the production of total biotin, true biotin and biotin vitamers by cells transformed with recombinant molecules containing the <i class="style-scope patent-text">Bacillus sphaericus </i>genes bioXWFDAYB, with or without the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecules pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, (produced as described in Examples 3E and 3D) as well as the plasmid pDIP18, are transformed into <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells using techniques described in Example 4 to produce, respectively, recombinant cells BL21/DE3-pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>and BL21/DE3-pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph</sup>, as well as BL21/DE3-pDIP18.</div>
    <div class="description-paragraph style-scope patent-text">The recombinant cells are cultured in shake flasks containing LB broth (10 g of bacto-tryptone, 5 g of bacto-yeast, and 10 g NaCl per liter of medium) plus about 75 μg/ml ampicillin and 0.5 g/L pimelic acid. When the cells reach an OD<sub class="style-scope patent-text">600 </sub>of about 0.7 units in LB broth, IPTG is added to a final concentration of 0.5 mM IPTG to induce expression of genes on the recombinant molecules. Supernatant samples are collected about 3 hours after IPTG induction and measured for total biotin, true biotin, and biotin vitamer content as described in Example 9.</div>
    <div class="description-paragraph style-scope patent-text">The amount of true biotin that is produced by the BL21/DE3-pDIPE<sup class="style-scope patent-text">col</sup>X<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>cultures is significantly higher than that produced by either BL21/DE3-pDIPX<sup class="style-scope patent-text">sph</sup>W<sup class="style-scope patent-text">sph</sup>F<sup class="style-scope patent-text">sph</sup>D<sup class="style-scope patent-text">sph</sup>A<sup class="style-scope patent-text">sph</sup>Y<sup class="style-scope patent-text">sph</sup>B<sup class="style-scope patent-text">sph </sup>(which produces primarily biotin vitamers) or BL21/DE3-pDIP18 cultures. The results indicate that recombinant cells transformed with the <i class="style-scope patent-text">Escherichia coli </i>bioE gene as well as the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWFDAYB genes are capable of converting increased amounts of biotin vitamers to true biotin, unlike recombinant cells transformed with recombinant molecules containing the <i class="style-scope patent-text">Bacillus sphaericus </i>bioXWFDAYB genes but lacking the <i class="style-scope patent-text">Escherichia coli </i>bioE gene.</div>
    <heading class="style-scope patent-text">Example 11</heading>
    <div class="description-paragraph style-scope patent-text">Production of recombinant molecules containing the <i class="style-scope patent-text">Escherichia coli </i>bioH nucleic acid sequence</div>
    <div class="description-paragraph style-scope patent-text">A. pCKRH′<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the coding region of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene operatively linked to a tac transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">An 820 bp DNA fragment containing the coding region, but lacking indigenous transcription control sequences, of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene, and denoted H′<sup class="style-scope patent-text">col</sup>, or bioH′, was produced by PCR amplification of a portion of W3110 <i class="style-scope patent-text">Escherichia coli </i>genomic DNA using primers #14 and #15. (SEQ ID NO:14 and SEQ ID NO:15, respectively) See FIG. 18<i class="style-scope patent-text">a. </i>Primers #14 and #15 (SEQ ID NO:14 and SEQ ID NO:15, respectively) are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00011" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="1" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #14 (SEQ ID NO:14)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GCTCTAGAGC <u class="style-scope patent-text">AAGGAGGA</u>CA ATA <u class="style-scope patent-text">ATG</u> AAT AAC ATC TGG</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">TGG</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">              Ribosome       Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">              Binding Site   Initiation Site</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #15 (SEQ ID NO:15)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ CCGGGTTCGA AACAT CTG CTT CAA CGC <figure-callout id="3" label="CAC CAG CAG" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">CAC CAG CAG</a></figure-callout> 3′</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #14 (SEQ ID NO:14) is complementary to a nucleic acid sequence containing the translation initiation site of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene. Primer #14 (SEQ ID NO:14) also contains an <i class="style-scope patent-text">Escherichia coli </i>consensus ribosome binding site, as shown. Primer #15 (SEQ ID NO:15) is complementary to a nucleic acid sequence including the 3′ end of the coding region of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene. Note that Primer #15 (SEQ ID NO:15) does not contain a stop codon in the appropriate reading frame. As such, expression of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene from the pCKRH′<sup class="style-scope patent-text">col </sup>recombinant molecule described hereinafter results in the production of a protein containing amino acids at its carboxyl terminus encoded by the sequences in pCKR101 immediately adjacent to the site at which H′<sup class="style-scope patent-text">col </sup>was inserted.</div>
    <div class="description-paragraph style-scope patent-text">The H′<sup class="style-scope patent-text">col </sup>PCR product was purified from an 0.7% agarose gel and ligated as shown in FIG. 18 to PCRII (see FIG. 18<i class="style-scope patent-text">b; </i>vector provided with the TA cloning kit from Invitrogen, San Diego, Calif.) to form plasmid pCRIIH′<sup class="style-scope patent-text">col</sup>, denoted pCRIIH′ in FIG. 18<i class="style-scope patent-text">c. </i> </div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 19, plasmid pCRIIH′<sup class="style-scope patent-text">col </sup>(depicted in FIG. 18<i class="style-scope patent-text">c</i>) was restricted with XbaI and HindIII to produce an 820 bp fragment containing the <i class="style-scope patent-text">Escherichia coli </i>bioH gene. The 820-bp fragment was ligated to vector pCKR101 (see FIG. 19<i class="style-scope patent-text">a </i>and Magnuson et al., ibid.) that had been restricted with XbaI and HindIII. The resulting recombinant molecule, pCKRH′<sup class="style-scope patent-text">col</sup>, denoted pCKRH′ in FIG. 19<i class="style-scope patent-text">b, </i>contains the <i class="style-scope patent-text">Escherichia coli </i>bioH gene operatively linked to a tac transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">B. pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of a recombinant molecule containing the coding region of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the coding regions of each of the genes of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon all operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">An 820-bp EcoRI fragment containing H′<sup class="style-scope patent-text">col </sup>was produced by restricting recombinant molecule pCKRH′<sup class="style-scope patent-text">col </sup>(produced as described in Example 11A and depicted in FIG. 19<i class="style-scope patent-text">b</i>) with EcoRI and isolating the 820 bp fragment (see FIG. <b class="style-scope patent-text">20</b>). The EcoRI fragment was ligated to recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1D and shown in FIG. 5<i class="style-scope patent-text">a</i>) that had been digested with EcoRI. The resulting recombinant molecule, referred to as pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>or pDIPH′AEBFCD, is shown in FIG. 20<i class="style-scope patent-text">a. </i> </div>
    <div class="description-paragraph style-scope patent-text">C. pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example describes the production of another recombinant molecule containing the coding region of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the coding regions of each of the genes of the <i class="style-scope patent-text">Escherichia coli </i>biotin operon all operatively linked to a bacteriophage T7 transcription control sequence.</div>
    <div class="description-paragraph style-scope patent-text">An 820 bp DNA fragment containing the coding region, but lacking indigenous transcription control sequences, of the <i class="style-scope patent-text">Escherichia coli </i>bioB gene, and denoted H<sup class="style-scope patent-text">col</sup>, or bioH, is produced by PCR amplification of a portion of W3110 <i class="style-scope patent-text">Escherichia coli </i>genomic DNA using primers #16 and #17 (SEQ ID NO:16 and SEQ ID NO:17, respectively). See FIG. 21<i class="style-scope patent-text">a. </i>Primers #16 and #17 (SEQ ID NO:16 and SEQ ID NO:17, respectively) are shown below.</div>
    <div class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00012" class="style-scope patent-text">
        <patent-tables tabstyle="MONOSPACE" frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table cols="2" colsep="0" rowsep="0" align="left" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #16 (SEQ ID NO:16)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GA<u class="style-scope patent-text">AGGAGGA</u>A AAAA <u class="style-scope patent-text">ATG </u> AAT AAC <figure-callout id="3" label="ATC TGG TG" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ATC TGG TG</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">     Ribosome      Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">     Binding Site  Initiation Site</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">Primer #17 (SEQ ID NO:17)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">5′ GCCAC <u class="style-scope patent-text">CTA</u> CAC CTG <figure-callout id="3" label="CTT CAA C" filenames="US6277609-drawings-page-3.png,US6277609-drawings-page-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">CTT CAA C</a></figure-callout> 3′</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">         Translation</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td morerows="0" valign="top" class="description-td style-scope patent-text"> </td>
                <td morerows="0" valign="top" class="description-td style-scope patent-text">         Stop Codon</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div class="description-paragraph style-scope patent-text">Primer #16 (SEQ ID NO:16) is complementary to a nucleic acid sequence containing the translation initiation site of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene. Primer #16 (SEQ ID NO:16) also contains an <i class="style-scope patent-text">Escherichia coli </i>consensus ribosome binding site, as shown. Primer #17 (SEQ ID NO:17) is complementary to a nucleic acid sequence immediately adjacent to and including a translation stop codon of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene.</div>
    <div class="description-paragraph style-scope patent-text">The H<sup class="style-scope patent-text">col </sup>PCR product is purified from an 0.7% agarose gel and ligated as shown in FIG. 21 to PCRII (see FIG. 21<i class="style-scope patent-text">b</i>) to form plasmid pCRIIH<sup class="style-scope patent-text">col</sup>, denoted PCRIIH in FIG. 21<i class="style-scope patent-text">c. </i> </div>
    <div class="description-paragraph style-scope patent-text">Referring to FIG. 22, plasmid pCRIIH<sup class="style-scope patent-text">col </sup>(depicted in FIG. 21<i class="style-scope patent-text">c</i>) is restricted with EcoRI to produce an 820-bp EcoRI fragment denoted H<sup class="style-scope patent-text">col </sup>or bioH. The EcoRI fragment is ligated to recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1D and shown in FIG. 5<i class="style-scope patent-text">a</i>) that is digested with EcoRI. The resulting recombinant molecule, referred to as pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>or pDIPHAEBFCD, is shown in FIG. 22<i class="style-scope patent-text">a. </i> </div>
    <heading class="style-scope patent-text">Example 12</heading>
    <div class="description-paragraph style-scope patent-text">Ability of pCKRH′<sup class="style-scope patent-text">col </sup>to rescue an <i class="style-scope patent-text">Escherichia coli </i>bioH<sup class="style-scope patent-text">−</sup> strain</div>
    <div class="description-paragraph style-scope patent-text">This example describes the ability of a recombinant molecule containing the coding region of the <i class="style-scope patent-text">Escherichia coli </i>bioH gene operatively linked to a tac transcription control sequence to complement an <i class="style-scope patent-text">Escherichia coli </i>bioH<sup class="style-scope patent-text">−</sup> strain, thereby enabling the transformed strain to grow in the absence of biotin.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant molecule pCKRH′<sup class="style-scope patent-text">col </sup>(produced as described in Example 11A and depicted in FIG. 19<i class="style-scope patent-text">b</i>) was transformed into <i class="style-scope patent-text">Escherichia coli </i>bioH<sup class="style-scope patent-text">−</sup> strain BM360 (obtained from Dr. A. Campbell, Stanford University, Stanford, Calif.) using conditions similar to those described in Example 4. An ampicillin resistant recombinant cell, denoted BM360-pCKRH′<sup class="style-scope patent-text">col</sup>, was selected and cultured in M9CAT medium. Recombinant cell BM360-pCKRH′<sup class="style-scope patent-text">col </sup>grew well in M9CAT medium, which lacks biotin, indicating that the <i class="style-scope patent-text">Escherichia coli </i>bioH gene present on pCKRH′<sup class="style-scope patent-text">col </sup>is operatively linked to the tac transcription control sequences. That is, H′<sup class="style-scope patent-text">col </sup>is expressed as a protein that has the activity of an <i class="style-scope patent-text">Escherichia coli </i>bioH gene product.</div>
    <heading class="style-scope patent-text">Example 13</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production using recombinant cells transformed with both pCKRH′<sup class="style-scope patent-text">col </sup>and pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example demonstrates that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produce more biotin than do cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cell BL21/DE3-pCKRH′<sup class="style-scope patent-text">col</sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>was produced by transforming BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>cells (produced as described in Example 4B) with recombinant molecule pCKRH′<sup class="style-scope patent-text">col </sup>(produced as described in Example 11A and depicted in FIG. 19<i class="style-scope patent-text">b</i>) using techniques similar to those described in Example 4 and selecting for recombinant cells resistant to both ampicillin and chloramphenicol. Recombinant cell BL21/DE3-pCKR101+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>was produced by transforming <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells with pCKR101 (see FIG. 19<i class="style-scope patent-text">a</i>) and recombinant molecule pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 1D and shown in FIG. 5<i class="style-scope patent-text">a</i>) and selecting for recombinant cells in a similar manner.</div>
    <div class="description-paragraph style-scope patent-text">BL21/DE3-pCKRH′<sup class="style-scope patent-text">col</sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and BL21/DE3-pCKR101+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>were cultured in shake flasks as described in Example 7. Supernatant samples were collected at 0, 3, and 6 hours after IPTG induction and measured for true biotin content using the microbiological assay cited in Example 7. The results, as shown in FIG. 23, demonstrate that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon (recombinant cell denoted as pDIPAEBFCD+pCKRH′) produced at least about 4 to about 5 times more true biotin than did cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon and a control vector (denoted pDIPAEBFCD+pCKR101).</div>
    <heading class="style-scope patent-text">Example 14</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production using recombinant cells transformed with pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example also demonstrates that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produce more biotin than do cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cell BL21/DE3-pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>is produced by transforming <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells with recombinant molecule pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 11B and depicted in FIG. 20<i class="style-scope patent-text">a</i>) as described in Example 4 and selecting for recombinant cells resistant to chloramphenicol.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cells BL21/DE3-pDIPH′<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 4B) are cultured in shake flasks as described in Example 7. Supernatant samples are collected at 0, 3, and 6 hours after IPTG induction and measured for true biotin content using the microbiological assay cited in Example 7. The results indicate that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produce significantly more true biotin than do cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text"> <i class="style-scope patent-text">Escherichia coli </i>BL21/DE-pCKRH<sup class="style-scope patent-text">1col </sup>′pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, as a derivative of the pD1P18 plasmid, was deposited with DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg 1b, D-38124 Braunschweig, Germany, an International Depository Authority under provisions of the Budapest Treaty, on Feb. 15, 1995. The deposited material was assigned accession number DSM 9733.</div>
    <heading class="style-scope patent-text">Example 15</heading>
    <div class="description-paragraph style-scope patent-text">Biotin production using recombinant cells transformed with pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup> </div>
    <div class="description-paragraph style-scope patent-text">This example also demonstrates that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produce more biotin than do cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cell BL21/DE3-pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>is produced by transforming <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3 cells with recombinant molecule pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 11C and depicted in FIG. 22<i class="style-scope patent-text">a</i>) as described in Example 4 and selecting for recombinant cells resistant to chloramphenicol.</div>
    <div class="description-paragraph style-scope patent-text">Recombinant cells BL2l/DE3-pDIPH<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>and BL21/DE3-pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col </sup>(produced as described in Example 4B) are cultured in shake flasks as described in Example 7. Supernatant samples are collected at 0, 3, and 6 hours after IPTG induction and measured for true biotin content using the microbiological assay cited in Example 7. The results indicate that recombinant cells transformed with both an <i class="style-scope patent-text">Escherichia coli </i>bioH gene and the <i class="style-scope patent-text">Escherichia coli </i>biotin operon produce significantly more true biotin than do cells transformed with just the <i class="style-scope patent-text">Escherichia coli </i>biotin operon.</div>
    <div class="description-paragraph style-scope patent-text"> <i class="style-scope patent-text">Escherichia coli </i>BL&lt;/DE3-pCKRH<sup class="style-scope patent-text">1col </sup>+pDIPA <sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, as a derivative of the pD1P18 plasmid, was deposited with DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkultren GmbH, Mascheroder Weg 1b, D-38124 Braunschweig, Germany, an International Depository Authority under provisions of the Budapest Treaty, on Feb. 15, 1995. The deposited material was assigned accession number DSM 9733.</div>
    <div class="description-paragraph style-scope patent-text"> <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3-pCKRH<sup class="style-scope patent-text">1col </sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>, a derivative of the pD1P18 plasmid, was deposited with DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg 1b, D-38124 Braunschweig, Germany, an International Depository Authority under provisions of the Budapest Treaty, on Feb. 15, 1995. The deposited nmaterial was assigned accession number DSM 9733.</div>
    <div class="description-paragraph style-scope patent-text">While various embodiments of the present invention have been described in detail, it is apparent that modifications and adaptations of those embodiments will occur to those skilled in the art. However, it is to be expressly understood that such modifications and adaptations are within the scope of the present invention, as set forth in the following claims.</div>
    <div class="description-paragraph style-scope patent-text">
      <sequence-cwu id="SEQLST-1" class="style-scope patent-text">
        <sequence-list-old-rules class="style-scope patent-text">
          <s-1 class="style-scope patent-text">
            <s-1-iii class="style-scope patent-text">17</s-1-iii>
          </s-1>
          <s-2 seq-no="1" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">35 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #1</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..30</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 31..35</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">1
AATCTTTTGA ATTCGGTTTA GGAGTCGATT ATGAC                                35</s-2-xi>
          </s-2>
          <s-2 seq-no="2" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">24 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #2</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..19)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (20..24)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">2
GCGCCACCCG GGAGAGTGAT TAAC                                            24</s-2-xi>
          </s-2>
          <s-2 seq-no="3" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">27 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #3</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..12)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (13..27)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">3
GTGTGTGGTA CCTTATTGGC AAAAAAA                                         27</s-2-xi>
          </s-2>
          <s-2 seq-no="4" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">23 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #4</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..23</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">4
TAATACGACT CACTATAGGG AGA                                             23</s-2-xi>
          </s-2>
          <s-2 seq-no="5" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">30 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #5</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..22)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (23..30)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">5
CATGATGAAT TCAAGGCAAG GTTTATGTAC                                      30</s-2-xi>
          </s-2>
          <s-2 seq-no="6" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">32 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #6</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..29</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 30..32</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">6
ATATGGGCCC AAACAAGAAA GGAGGGTTCA TG                                   32</s-2-xi>
          </s-2>
          <s-2 seq-no="7" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">25 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #7</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..25</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">7
ATATATCCCG GGTTAACTCA AATTG                                           25</s-2-xi>
          </s-2>
          <s-2 seq-no="8" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">31 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #8</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..15)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (16..31)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">8
CCCGCGGCCG CTCATTCATT TTAAATCCCC C                                    31</s-2-xi>
          </s-2>
          <s-2 seq-no="9" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">31 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #9</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..30</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 31</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">9
TGAATGAGCG GCCGCGGGAG GGATGAGGGC A                                    31</s-2-xi>
          </s-2>
          <s-2 seq-no="10" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">27 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #10</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..15)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (16..27)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">10
CTATATCCCG GGAATTCACT AAACATT                                         27</s-2-xi>
          </s-2>
          <s-2 seq-no="11" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">29 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #11</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..18)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (19..29)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">11
GATATAAGCT TCAAACAATT ATACAATCC                                       29</s-2-xi>
          </s-2>
          <s-2 seq-no="12" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">37 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #12</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..37</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">12
TTTCCCAAGC TTTGCACACT TCTGTTTCGT ATCCTCA                              37</s-2-xi>
          </s-2>
          <s-2 seq-no="13" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">39 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Bacillus sphaericus</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">ATCC No. 10208</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #13</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..39)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">13
CCTGGGAAGC TTTCATTGAA CATTTTGTGA AAACCATCA                            39</s-2-xi>
          </s-2>
          <s-2 seq-no="14" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">41 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #14</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..23</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 24..41</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">14
GCTCTAGAGC AAGGAGGACA ATAATGAATA ACATCTGGTG G                         41</s-2-xi>
          </s-2>
          <s-2 seq-no="15" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">36 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #15</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..15)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (16..36)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">15
CCGGGTTCGA AACATCTGCT TCAACGCCAC CAGCAG                               36</s-2-xi>
          </s-2>
          <s-2 seq-no="16" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">31 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #16</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">5′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 1..14</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> 15..31</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">16
GAAGGAGGAA AAAAATGAAT AACATCTGGT G                                    31</s-2-xi>
          </s-2>
          <s-2 seq-no="17" class="style-scope patent-text">
            <s-2-i class="style-scope patent-text">
              <s-2-i-a class="style-scope patent-text">21 base pairs</s-2-i-a>
              <s-2-i-b class="style-scope patent-text">nucleic acid</s-2-i-b>
              <s-2-i-c class="style-scope patent-text">single</s-2-i-c>
              <s-2-i-d class="style-scope patent-text">linear</s-2-i-d>
            </s-2-i>
            <s-2-ii class="style-scope patent-text">
              <s-2-ii-mt class="style-scope patent-text">DNA (genomic)</s-2-ii-mt>
            </s-2-ii>
            <s-2-iii class="style-scope patent-text">YES</s-2-iii>
            <s-2-iv class="style-scope patent-text">NO</s-2-iv>
            <s-2-vi class="style-scope patent-text">
              <s-2-vi-a class="style-scope patent-text">Escherichia coli</s-2-vi-a>
              <s-2-vi-b class="style-scope patent-text">W3110</s-2-vi-b>
            </s-2-vi>
            <s-2-vii class="style-scope patent-text">
              <s-2-vii-b class="style-scope patent-text">Primer #17</s-2-vii-b>
            </s-2-vii>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">3′UTR</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (1..5)</s-2-ix-b>
            </s-2-ix>
            <s-2-ix class="style-scope patent-text">
              <s-2-ix-a class="style-scope patent-text">CDS</s-2-ix-a>
              <s-2-ix-b class="style-scope patent-text"> complement (6..21)</s-2-ix-b>
            </s-2-ix>
            <s-2-xi class="style-scope patent-text">17
GCCACCTACA CCTGCTTCAA C                                               21</s-2-xi>
          </s-2>
        </sequence-list-old-rules>
      </sequence-cwu>
    </div>
    
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(24)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM28690763" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <claim-statement class="style-scope patent-text">What is claimed is: </claim-statement>
    <div class="claim style-scope patent-text"> <div num="1" id="US-6277609-B1-CLM-00001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. A biotin overproducing recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, said recombinant cell being capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="2" id="US-6277609-B1-CLM-00002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">2. The recombinant cell of claim <b class="style-scope patent-text">1</b> selected from the group consisting of bacteria and yeast.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="3" id="US-6277609-B1-CLM-00003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">3. The recombinant cell of claim <b class="style-scope patent-text">1</b>, wherein said recombinant cell is of the species <i class="style-scope patent-text">Escherichia coli. </i> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="4" id="US-6277609-B1-CLM-00004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">4. The recombinant cell of claim <b class="style-scope patent-text">1</b>, wherein said <i class="style-scope patent-text">Escherichia coli </i>bioH gene is operatively linked to a transcription control sequence to form a recombinant molecule.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="5" id="US-6277609-B1-CLM-00005" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">5. The recombinant cell of claim <b class="style-scope patent-text">4</b>, wherein said transcription control sequence comprises a bacteriophage T7 or a tac transcription control sequence.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="6" id="US-6277609-B1-CLM-00006" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">6. The recombinant cell of claim <b class="style-scope patent-text">1</b>, wherein said recombinant cell is also transformed with at least one nucleic acid sequence selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="7" id="US-6277609-B1-CLM-00007" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. The recombinant cell of claim <b class="style-scope patent-text">6</b>, wherein said <i class="style-scope patent-text">Escherichia coli </i>bioH gene and said nucleic acid sequence are operatively linked to at least one transcription control sequence to form at least one recombinant molecule.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="8" id="US-6277609-B1-CLM-00008" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. The recombinant cell of claim <b class="style-scope patent-text">1</b> transformed with (a) an <i class="style-scope patent-text">Escherichia coli </i>bioA gene; (b) an <i class="style-scope patent-text">Escherichia coli </i>bioB gene; (c) an <i class="style-scope patent-text">Escherichia coli </i>bioC gene; (d) an <i class="style-scope patent-text">Escherichia coli </i>bioD gene; (e) an <i class="style-scope patent-text">Escherichia coli </i>bioE gene; (f) an <i class="style-scope patent-text">Escherichia coli </i>bioF gene; and (g) an <i class="style-scope patent-text">Escherichia coli </i>bioH gene.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="9" id="US-6277609-B1-CLM-00009" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. The recombinant cell of claim <b class="style-scope patent-text">1</b>, wherein said recombinant cell is capable of producing at least about fifty percent more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="10" id="US-6277609-B1-CLM-00010" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. The recombinant cell of claim <b class="style-scope patent-text">1</b> comprising an <i class="style-scope patent-text">Escherichia coli </i>transformed with recombinant molecule pCRH<sup class="style-scope patent-text">′col</sup>.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="11" id="US-6277609-B1-CLM-00011" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">11. The recombinant cell of claim <b class="style-scope patent-text">1</b>, wherein the said recombinant cell is <i class="style-scope patent-text">Escherichia coli </i>BL21/DE3-pCKRH′<sup class="style-scope patent-text">col</sup>+pDIPA<sup class="style-scope patent-text">col</sup>E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="12" id="US-6277609-B1-CLM-00012" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">12. The recombinant cell of claim <b class="style-scope patent-text">1</b> produced by a method comprising:</div>
      <div class="claim-text style-scope patent-text">(a) operatively linking said <i class="style-scope patent-text">Escherichia coli </i>bioH gene to a transcription control sequence to form a recombinant molecule; and </div>
      <div class="claim-text style-scope patent-text">(b) transforming said recombinant molecule into a host cell to form said recombinant cell. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="13" id="US-6277609-B1-CLM-00013" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">13. The recombinant cell of claim <b class="style-scope patent-text">12</b>, wherein indigenous production of biotin by said host cell is deregulated.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="14" id="US-6277609-B1-CLM-00014" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">14. The recombinant cell of claim <b class="style-scope patent-text">6</b> produced by a method comprising:</div>
      <div class="claim-text style-scope patent-text">(a) operatively linking said <i class="style-scope patent-text">Escherichia coli </i>bioH gene and at least one nucleic acid sequence selected from said group to at least one transcription control sequence to form at least one recombinant molecule; and </div>
      <div class="claim-text style-scope patent-text">(b) transforming said recombinant molecule(s) into a host cell to form said recombinant cell. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="15" id="US-6277609-B1-CLM-00015" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">15. A recombinant molecule comprising an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, operatively linked to a transcription control sequence selected from the group consisting of bacterial and yeast transcription control sequences.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="16" id="US-6277609-B1-CLM-00016" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">16. The recombinant molecule of claim <b class="style-scope patent-text">15</b> further comprising at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes operatively linked to at least one transcription control sequence selected from the group consisting of bacterial and yeast transcription control sequences.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="17" id="US-6277609-B1-CLM-00017" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">17. The recombinant molecule of claim <b class="style-scope patent-text">15</b>, wherein said transcription control sequence is selected from the group consisting of Escherichia, Bacillus, Pseudomonas, Salmonella, Corynebacterium, and Saccharomyces transcription control sequences.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="18" id="US-6277609-B1-CLM-00018" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">18. The recombinant molecule of claim <b class="style-scope patent-text">15</b>, wherein said transcription control sequence comprises a bacteriophage T7 or tac transcription control sequence.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="19" id="US-6277609-B1-CLM-00019" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">19. The recombinant molecule of claim <b class="style-scope patent-text">15</b>, wherein said recombinant molecule comprises a nucleic acid sequence selected from the group consisting of H<sup class="style-scope patent-text">col</sup>, B<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>, E<sup class="style-scope patent-text">col</sup>B<sup class="style-scope patent-text">col</sup>D<sup class="style-scope patent-text">col</sup>A<sup class="style-scope patent-text">col</sup>F<sup class="style-scope patent-text">col</sup>C<sup class="style-scope patent-text">col</sup>H<sup class="style-scope patent-text">col</sup>.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="20" id="US-6277609-B1-CLM-00020" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">20. The recombinant molecule of claim <b class="style-scope patent-text">15</b>, wherein said recombinant molecule is pCKRH′<sup class="style-scope patent-text">col</sup>.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="21" id="US-6277609-B1-CLM-00021" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">21. A method to produce a recombinant cell comprising transforming a host cell with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, said recombinant cell being capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="22" id="US-6277609-B1-CLM-00022" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">22. The method of claim <b class="style-scope patent-text">21</b> further comprising transforming said host cell with at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="23" id="US-6277609-B1-CLM-00023" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">23. A method to produce biotin comprising:</div>
      <div class="claim-text style-scope patent-text">(a) culturing in a medium effective to produce biotin a biotin overproducing recombinant cell transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene, said recombinant cell being capable of producing more biotin than a cell not transformed with an <i class="style-scope patent-text">Escherichia coli </i>bioH gene; and </div>
      <div class="claim-text style-scope patent-text">(b) recovering biotin produced thereby. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="24" id="US-6277609-B1-CLM-00024" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">24. The method of claim <b class="style-scope patent-text">23</b>, wherein said recombinant cell is also transformed with at least one nucleic acid selected from the group consisting of <i class="style-scope patent-text">Escherichia coli </i>bioA, bioB, bioC, bioD, bioE, and bioF genes.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (13)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3393129A/en"><a id="link" href="#" class="style-scope state-modifier">US3393129A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1964-12-23</span>
                    <span class="td style-scope patent-result">1968-07-16</span>
                    <span class="td style-scope patent-result">Takeda Chemical Industries Ltd</span>
                    <span class="td style-scope patent-result">Method for producing d-biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4563426A/en"><a id="link" href="#" class="style-scope state-modifier">US4563426A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1980-05-15</span>
                    <span class="td style-scope patent-result">1986-01-07</span>
                    <span class="td style-scope patent-result">Nippon Zeon Co., Ltd.</span>
                    <span class="td style-scope patent-result">Process for producing biotin-vitamers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS61149091A/en"><a id="link" href="#" class="style-scope state-modifier">JPS61149091A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1984-12-24</span>
                    <span class="td style-scope patent-result">1986-07-07</span>
                    <span class="td style-scope patent-result">Nippon Soda Co Ltd</span>
                    <span class="td style-scope patent-result">Duplex dna to code biotin synthase, bacterium containing same and production of biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS61202686A/en"><a id="link" href="#" class="style-scope state-modifier">JPS61202686A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-03-05</span>
                    <span class="td style-scope patent-result">1986-09-08</span>
                    <span class="td style-scope patent-result">Shiseido Co Ltd</span>
                    <span class="td style-scope patent-result">Novel microorganism, and production of biotin by fermentation using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS62155081A/en"><a id="link" href="#" class="style-scope state-modifier">JPS62155081A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-12-27</span>
                    <span class="td style-scope patent-result">1987-07-10</span>
                    <span class="td style-scope patent-result">Shiseido Co Ltd</span>
                    <span class="td style-scope patent-result">Novel microorganism and production of biotin by fermentation with said microorganism 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0240105A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0240105A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-03-25</span>
                    <span class="td style-scope patent-result">1987-10-07</span>
                    <span class="td style-scope patent-result">Nippon Zeon Co., Ltd.</span>
                    <span class="td style-scope patent-result">A gene coding for biotin synthetase and utilization thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0266240A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0266240A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-09-30</span>
                    <span class="td style-scope patent-result">1988-05-04</span>
                    <span class="td style-scope patent-result">Transgene S.A.</span>
                    <span class="td style-scope patent-result">Cloning of the bioA, bioD, bioF, bioC and bioH genes of Bacillus sphaericus, vectors and transformed cells, and process for the preparation of biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0316229A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0316229A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-07</span>
                    <span class="td style-scope patent-result">1989-05-17</span>
                    <span class="td style-scope patent-result">Shiseido Company Limited</span>
                    <span class="td style-scope patent-result">Microorganism having low acetate forming capability, and process for production of useful substrate using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB2216530A/en"><a id="link" href="#" class="style-scope state-modifier">GB2216530A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-03-22</span>
                    <span class="td style-scope patent-result">1989-10-11</span>
                    <span class="td style-scope patent-result">Mini Agriculture &amp; Fisheries</span>
                    <span class="td style-scope patent-result">Genetic material for expression of biotin synthetase enzymes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0375525A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0375525A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-12-16</span>
                    <span class="td style-scope patent-result">1990-06-27</span>
                    <span class="td style-scope patent-result">Transgene S.A.</span>
                    <span class="td style-scope patent-result">Use of a recombinant strain of Escherichia coli for the production of biothin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0379428A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0379428A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-01-19</span>
                    <span class="td style-scope patent-result">1990-07-25</span>
                    <span class="td style-scope patent-result">Transgene S.A.</span>
                    <span class="td style-scope patent-result">Improved method for the expression of biotin in bacillus sphaericus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5110731A/en"><a id="link" href="#" class="style-scope state-modifier">US5110731A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-26</span>
                    <span class="td style-scope patent-result">1992-05-05</span>
                    <span class="td style-scope patent-result">Amgen, Inc.</span>
                    <span class="td style-scope patent-result">System for biotin synthesis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5212058A/en"><a id="link" href="#" class="style-scope state-modifier">US5212058A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-05-09</span>
                    <span class="td style-scope patent-result">1993-05-18</span>
                    <span class="td style-scope patent-result">Massachusetts Institute Of Technology</span>
                    <span class="td style-scope patent-result">Nucleic acid encoding ubiquitin-specific proteases 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (18)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Brown et al., "The Production of Biotin by Genetically Modified Micro-organisms", pp. 295-326, 1991 Biotechnology and Genetic Engineering Reviews, vol. 9, Dec.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cleary et al., "Location of Promoter and Operator Sites in the Biotin Gene Cluster of Escherichia coli", pp. 2219-2223, 1972, Proc. Natl. Acad. Sci., vol. 69.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Eisenberg, "Biosynthesis of Biotin and Lipoic Acid", pp. 544-550, 1987, in Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology, Neidhardt, F.C. et al., eds., American Society of Biology, Washington, D.C.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gloeckler et al., "Cloning and Characterization of the Bacillus sphaericus Genes Controlling the Bioconversion of Pimelate into Dethiobiotin", pp. 63-70, 1990, Gene, vol. 87.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Guha et al., "Divergent Orientation of Transcription from the Biotin Locus of Escherichia coli", pp. 53-62, 1971, J. Mol. Biol., vol. 56.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Izumi et al., from "Microbial Production of Biotin", pp. 242-243, 1989, in Biotechnology of Vitamins, Pigments, and Growth Factors, Elsevier Applied Science (E.J. Vandamme, ed.).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Magnuson et al., "Cloning and Nucleotide Sequence of the fabD Gene Encoding Malonyl Coenzyme A-acyl Carrier Protein Transacylase of Escherichia coli", pp. 262-266, 1992, FEBS Letters, vol. 229.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ogata et al., "Studies on Biosynthesis on Biotin by Microorganisms. Part I. Accumulation of Biotin-Vitamers by Various Microorganisms", pp. 889-894, 1965, Agr. Biol. Chem., vol. 29.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ogata et al., "Studies on Biosynthesis on Biotin by Microorganisms. Part II. Identification of Biotin-Vitamers Accumulated by Various Microorganisms", pp. 895-901, 1965, Agr. Biol. Chem., vol. 29.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ogata, "Microbial Synthesis of Dethiobiotin and Biotin", pp. 390-395, 1970, Methods in Enzymology, vol. 17a.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ohsawa et al., "Bioconversion of Pimelic Acid into Biotin by Bacillus sphaericus bioB Transformants", pp. 121-124, 1992, J. Ferment. Bioeng., vol. 73.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ohsawa et al., Cloning of the Biotin Synthetase Gene from Bacillus sphaericus and Expression in Escherichia coli and Bacilli, pp. 39-48, 1989, Gene, vol. 80.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      O'Regan et al., "Nucleotide Sequence of the bioH Gene of Escherichia coli", p. 8004, 1989, Nucleic Acids Research, vol. 17.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Otsuka et al., "The Escherichia coli Biotin Biosynthetic Enzyme Sequences Predicted from the Nucleotide Sequence of the bio Operon", pp. 19577-19585, 1988, J. Biol. Chem., vol. 263, Dec.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ploux et al., "Investigation of the First Step of Biotin Biosynethesis of Bacillus sphaericus", pp. 685-690, 1992, Biochem. J., vol. 287.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sabatie et al., "Biotin formation by recombinant strains of Escherichia coli: influence of the host physiology", pp. 29-50, 1991, J. Biotech., vol. 20.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Singer et al. (1991) Gene 106, 1-6.*
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Studier et al., "Use of Bacteriophage T7 RNA Polymerase to Direct Selective High-Level Expression of Cloned Genes", pp. 113-130, 1986, J. Mol. Biol., vol. 189.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6365388B1/en"><a id="link" href="#" class="style-scope state-modifier">US6365388B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-27</span>
                    <span class="td style-scope patent-result">2002-04-02</span>
                    <span class="td style-scope patent-result">Roche Vitamins, Inc.</span>
                    <span class="td style-scope patent-result">Biotin biosynthetic genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102559719A/en"><a id="link" href="#" class="style-scope state-modifier">CN102559719A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-20</span>
                    <span class="td style-scope patent-result">2012-07-11</span>
                    <span class="td style-scope patent-result">上海海洋大学</span>
                    <span class="td style-scope patent-result">Carboxylesterase gene and protein coded by same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107099497A/en"><a id="link" href="#" class="style-scope state-modifier">CN107099497A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-06-09</span>
                    <span class="td style-scope patent-result">2017-08-29</span>
                    <span class="td style-scope patent-result">浙江大学</span>
                    <span class="td style-scope patent-result">A kind of plasmid for promoting biotin synthesis, cell and its promotion method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2018022595A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2018022595A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-07-25</span>
                    <span class="td style-scope patent-result">2018-02-01</span>
                    <span class="td style-scope patent-result">Invista Textiles (U.K.) Limited</span>
                    <span class="td style-scope patent-result">Materials and methods utilizing biotin producing mutant hosts for the production of 7-carbon chemicals 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2230114C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2230114C2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-06-10</span>
                    <span class="td style-scope patent-result">Mutant glutamine synthetase, dna fragment, strain of escherichia coli as p roducer of l-glutamine and method for preparing l-amino acids 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100838038B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100838038B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-12</span>
                    <span class="td style-scope patent-result">- - a microorganism of corynebacterium genus having enhanced l-lysine productivity and a method of producing l-lysine using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100546733B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100546733B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-26</span>
                    <span class="td style-scope patent-result">Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100838035B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100838035B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-12</span>
                    <span class="td style-scope patent-result">- - a microorganism of corynebacterium genus having enhanced l-lysine productivity and a method of producing l-lysine using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU784733B2/en"><a id="link" href="#" class="style-scope state-modifier">AU784733B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-06-08</span>
                    <span class="td style-scope patent-result">Process for producing a target fermentation product 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/HU196843B/en"><a id="link" href="#" class="style-scope state-modifier">HU196843B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-01-30</span>
                    <span class="td style-scope patent-result">Process for producing l-lysine 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20130082124A/en"><a id="link" href="#" class="style-scope state-modifier">KR20130082124A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-07-18</span>
                    <span class="td style-scope patent-result">Corynebacterium sp. having xylose availability and process for preparing l-lysine employing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2484448A1/en"><a id="link" href="#" class="style-scope state-modifier">FR2484448A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1981-12-18</span>
                    <span class="td style-scope patent-result">
  PROCESS FOR PRODUCING L-ARGININE BY FERMENTATION
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100837844B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100837844B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-13</span>
                    <span class="td style-scope patent-result">- - Microoragnism of Corynbacterium genus with an enhanced L-glutamic acid productivity and method of producing L-glutamic acid using the microorganism 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2002512802A/en"><a id="link" href="#" class="style-scope state-modifier">JP2002512802A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-08</span>
                    <span class="td style-scope patent-result">
  Aromatic metabolism / Microbial production of substance III
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4352716B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4352716B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-10-28</span>
                    <span class="td style-scope patent-result">
  Inosine-producing bacteria belonging to the genus Bacillus and a method for producing inosine
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/14135301382322711545"><a id="link" href="#" class="style-scope state-modifier">Perkins et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993</span>
                    <span class="td style-scope patent-result">Biosynthesis of riboflavin, biotin, folic acid, and cobalamin</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier">US6277609B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-21</span>
                    <span class="td style-scope patent-result">Method to produce biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3848297B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3848297B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-11-22</span>
                    <span class="td style-scope patent-result">
  Microorganism producing riboflavin and method for producing riboflavin using the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5445952A/en"><a id="link" href="#" class="style-scope state-modifier">US5445952A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-29</span>
                    <span class="td style-scope patent-result">Method to produce biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7220572B2/en"><a id="link" href="#" class="style-scope state-modifier">US7220572B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-22</span>
                    <span class="td style-scope patent-result">Method for producing L-leucine 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3926292B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3926292B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-06-06</span>
                    <span class="td style-scope patent-result">
  Microorganism producing riboflavin and method for producing riboflavin using the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP4168566A1/en"><a id="link" href="#" class="style-scope state-modifier">EP4168566A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-04-26</span>
                    <span class="td style-scope patent-result">Methods for producing biotin in genetically modified microorganisms 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3916251B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3916251B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-16</span>
                    <span class="td style-scope patent-result">
  Method for fermenting clavam derivatives that maintains low levels of ammonia and urea in the fermentation medium
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6020173A/en"><a id="link" href="#" class="style-scope state-modifier">US6020173A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-01</span>
                    <span class="td style-scope patent-result">Microorganism resistant to threonine analogue and production of biotin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1543138B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1543138B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-08-02</span>
                    <span class="td style-scope patent-result">Process for producing vitamin b6 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060228785A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060228785A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-12</span>
                    <span class="td style-scope patent-result">Recombinant microorganism for the production of vitamin b6 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0146929A2/en"><a id="link" href="#" class="style-scope state-modifier">EP0146929A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-07-03</span>
                    <span class="td style-scope patent-result">Microorganism of the genus Serratia containing a hybrid plasmid and process for preparing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117897476A/en"><a id="link" href="#" class="style-scope state-modifier">CN117897476A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-04-16</span>
                    <span class="td style-scope patent-result">Microbial cell factory for producing vitamin B compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11243976A/en"><a id="link" href="#" class="style-scope state-modifier">JPH11243976A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-14</span>
                    <span class="td style-scope patent-result">Unicellular or multicellular organism, threonine aldolase gene, structure containing the same gene, vector containing the same gene, transformant organism, production of riboflavin and use of organism, gene or vector 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationPriorityApps" class="scroll-target style-scope patent-result">
              Priority Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier">US08/001,063</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1993-01-06</span>
                    <span class="td nowrap style-scope patent-result">1993-01-06</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Method to produce biotin 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6277609B1/en"><a id="link" href="#" class="style-scope state-modifier">US08/001,063</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1993-01-06</span>
                    <span class="td style-scope patent-result">Method to produce biotin 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1993-01-06</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: ZEAGEN, INC., COLORADO</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:EDDY, CHRISTINA K.;CAMPBELL, JOHN W.;REEL/FRAME:006395/0615</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 19930104</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1993-06-28</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: UNIVERSAL FOODS CORPORATION, WISCONSIN</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:ZEAGEN, INC.;REEL/FRAME:006599/0443</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 19930617</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1994-08-01</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: BASF AKTIENGESELLSCHAFT, GERMANY</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:UNIVERSAL FOODS CORP.;REEL/FRAME:007080/0923</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 19940727</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2001-12-03</span>
                    <span class="td nowrap style-scope patent-result">FEPP</span>
                    <span class="td nowrap style-scope patent-result">Fee payment procedure</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-02-26</span>
                    <span class="td nowrap style-scope patent-result">CC</span>
                    <span class="td nowrap style-scope patent-result">Certificate of correction</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2005-01-26</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-03-02</span>
                    <span class="td nowrap style-scope patent-result">REMI</span>
                    <span class="td nowrap style-scope patent-result">Maintenance fee reminder mailed</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-08-21</span>
                    <span class="td nowrap style-scope patent-result">LAPS</span>
                    <span class="td nowrap style-scope patent-result">Lapse for failure to pay maintenance fees</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-09-21</span>
                    <span class="td nowrap style-scope patent-result">STCH</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent discontinuation</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-10-13</span>
                    <span class="td nowrap style-scope patent-result">FP</span>
                    <span class="td nowrap style-scope patent-result">Lapsed due to failure to pay maintenance fee</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090821</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2464652718" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2464652718" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=339611036" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>